Mask proteins are co-factors of Yorkie/YAP in the Hippo signaling pathway by Sidor, C.M.
Mask proteins are co-factors of Yorkie/YAP 
in the Hippo signaling pathway 
 
 
Clara M. Sidor 
 
University College London 
and 
Cancer Research UK London Research Institute 
PhD Supervisor: Dr Barry J. Thompson 
 
A thesis submitted for the degree of 
Doctor of Philosophy 
University College London 
September 2011 
 2 
Declaration 
 
I, Clara M. Sidor, confirm that the work presented in this thesis is my own.  Where 
information has been derived from other sources, I confirm that this has been indicated 
in the thesis. 
 3 
Abstract 
 
Mask proteins are cofactors of Yki/YAP in the Hippo signaling pathway 
One of the key questions in developmental biology is how tissue growth is controlled to 
give rise to organs of specific sizes and shapes. Although some genes and pathways 
involved in the genetic and environmental control of tissue growth have been 
uncovered, the understanding of this process remains incomplete. In order to find new 
regulators of growth we carried out an in vivo RNAi screen in the Drosophila wing. I 
participated in the validation of candidate genes from the screen and identified the 
mask gene as an essential regulator of tissue growth acting in the Hippo signaling 
pathway. This pathway acts via the Yorkie (Yki)/Yes-associated protein (YAP) 
transcriptional co-activator to control tissue growth in both Drosophila and mammals.  
Yki/YAP translocates from the cytoplasm to the nucleus to activate target genes, a 
process that is negatively regulated by the Warts kinase, one of the core components 
of the Hippo pathway.  I found that Mask is an essential positive regulator of Yki acting 
downstream of Warts.  Mask is required for normal tissue growth, for the expression of 
Yki target genes and for the overgrowth phenotype caused by Yki overexpression.  
Mask binds to Yki and the two proteins translocate from the cytoplasm to the nucleus 
together in response to various stimuli.  My results show that Mask acts in the nucleus 
to promote Yki target gene activation.  Finally, Mask’s function appears to be 
conserved in humans, as two human homologues of Mask (hMask1 and hMask2) 
translocate with YAP to the cytoplasm upon cell contact inhibition, and we 
demonstrate that one of these homologues promotes YAP’s transactivation function.  
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Chapter 1.  Introduction 
 Evolution has given rise to a great diversity of animal forms, each adapted to 
different environmental niches. Animal tissues come in an astonishing variety of sizes 
and shapes, and the question of how tissue size is controlled has fascinated 
developmental biologists for decades. First, I am going to introduce the question of 
size control in animal development. I will then focus on the growth effectors acting 
downstream of the developmental signaling pathways controlling tissue size, in 
particular on the recently discovered Hippo signaling pathway, which controls cell 
survival and cell proliferation in all animals.  
1.1 Growth control in animals 
Vertebrate skeletons are a very good illustration of how diversity in forms can arise. 
Most bones of the vertebrate skeleton have homologues in all vertebrates, but they 
exhibit simple variations in size and proportions that have evolved to adapt to different 
environments and functions. For instance, the human arm is remarkably homologous to 
the bat’s anterior limb (Fig 1.1 A). The most striking difference, scale aside, is the 
change in proportions of bones that has allowed formation of the human arm and hand, 
adapted to manipulation, and formation of the bat wing, adapted to flight. An 
examination of our closer relatives such as the chimpanzee or the gorilla also illustrates 
how body size and proportions can evolve from a common ancestor and produce 
different body shapes (Fig 1.1 B). Within a species, nutrition has a profound effect on 
body size. From flies to human, deprivation in nutrients during development lead to an 
adult of a smaller size (Fig 1.1 C). This nutrient dependent growth control mechanism 
is mediated by the Insulin/TOR signaling pathway (Parker, 2011). Thus, organ size is 
determined by intrinsic genetic mechanisms that determine the proportions of the 
body, and can be modulated by extrinsic signals in response to environmental 
conditions. 
The developmental mechanisms that control body and organ size are still poorly 
understood. One of the most fascinating questions is how organs “know” which size 
they should grow to. Evidence for an intrinsic organ size control mechanism comes 
from transplantation experiments. In rats and mice, it was found that infant organs 
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(kidney, heart or thymus) transplanted to adult animals grow to their correct adult size 
(Dittmer et al., 1974; METCALF, 1963; Silber, 1976). The same is true of Drosophila 
wing imaginal discs, which are the larval precursors of the adult wing. Immature wing 
imaginal discs from young larvae transplanted into adult hosts grow to their normal 
final size (Bryant and Simpson, 1984). Thus, there is a conserved intrinsic mechanism 
that allows organs to sense their mass and grow to their correct size. Some organs are 
also capable of monitoring their size after their development is complete. For instance, 
the rat liver is able to regenerate to its full size after ablation of 2/3 of its volume, and 
the human liver is also capable of regeneration (Michalopoulos and DeFrances, 1997). 
The size of an organ depends on the number and size of its cells. However, organs do 
not control their size by counting their cell number and measuring single cells size. 
Various experiments have shown that organ size is sensed in a more global way, as a 
measure of their total volume. One particularly striking piece of evidence comes from 
spontaneous variations in ploidy found in salamanders. Salamanders are diploid, but at a 
low frequency, some individuals are born triploid and even more rarely with higher 
degrees of polyploidy. Cells from polyploid animals contain more DNA and are bigger 
than cells from diploids, but this increase in cell size is compensated by a reduction in 
cell number that results in a normal body size (Fankhauser, 1941). In the Drosophila 
wing disc, increases or decreases in cell proliferation rates caused by alterations in the 
expression of cell cycle genes are compensated by decreases or increases in cell size, 
leaving the organ final size relatively unchanged (Neufeld et al., 1998; Weigmann et al., 
1997).  
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Figure 1.1: Intrinsic and extrinsic control of size, the influence of genes and 
environment.  
(A) human and bat anterior limbs, Source: Encyclopaedia Britanica  (B) Illustration from T. H. 
Huxley’s book Man’s place in Nature. From left to right: Gibbon, Orang-outang, Chimpanzee, 
Gorilla and Man skeletons. They are all at the same scale apart from the Gibbon which is drawn 
twice its natural size. (C) Drosophila melanogaster adult flies; top: control fly; bottom: fly starved 
during its development. 
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Long before the molecular mechanisms of organ size control started to be unravelled, 
classical regeneration experiments in various organisms led to the hypothesis that cells 
within an organ perceive positional information and activate genes in function of their 
position. Regeneration experiments performed by Bohn in the 1960’s have shown that 
when the distal part of a cockroach tibia is grafted on a host limb that has been 
sectioned more proximally, cells at the boundary are confronted with cells they are 
normally not adjacent with and proliferate, regenerating the missing parts (Bohn, 1967; 
Fig 1.2). Positional information is encoded by gradients of secreted molecules called 
morphogens that diffuse from their source of production and induce different target 
genes in function of their concentration, thereby controlling tissue patterning and 
tissue growth (Lawrence, 2001). 
 
Figure 1.2: Regeneration in the cockroach l imb 
Graft of the distal part (position E) of a cockroach tibia to a more proximal position (position A) 
in a host leads to intercalary proliferation and regeneration of the missing parts (B-C-D) 
(Illustration from French et al., 1976).  
 
 
The first morphogen to be identified in animals, the transcription factor bicoid, was 
discovered in Drosophila early embryos where it forms a concentration gradient 
essential for anteroposterior patterning (Driever and Nüsslein-Volhard, 1988). Since 
then, more morphogens have been discovered, and their essential roles in tissue 
growth and patterning in animals have been brought to light. Most of the 
understanding of the mechanisms of tissue growth control originates from studies in 
Drosophila, which has proven to be a very good model to study growth.  
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1.2 Drosophila as a model to study growth  
All animal embryos face two key challenges. First, before they develop specialised 
organs for nutrient intake, they cannot grow. Second, cell proliferation is incompatible 
with highly differentiated cells as it disrupts cell architecture and metabolism. Thus 
proliferation is usually limited to early stages of embryonic development prior to 
differentiation, and different species use different strategies to allow later growth, such 
as uncoupling of cell growth and cell division or maintaining pools of stem cells (P. H. 
O’Farrel, Cell growth, Chapter 1). Drosophila development remarkably overcomes these 
two constraints (Fig 1.3 A). The fertilized egg contains enough nutrients deposited by 
the mother to fully develop into a larva with a mouth and a digestive system. Larval 
development is divided into 3 larval stages separated by moults, and lasts 4 days 
during which the larva feeds and grows by two-hundred-fold. Most of the larval growth 
occurs by increases in cell size without cell divisions, via cell growth and endo-
replicative cycles. Drosophila adult structures derive from undifferentiated epithelial 
structures called imaginal discs (Fig 1.3 B) that are specified early in the embryo and 
acquire their identity in response to positional cues. Imaginal discs undergo extensive 
cell proliferation throughout larval development without differentiating. In response to 
a hormonal signal, larvae crawl out of the source of food to pupariate. At pupariation, 
imaginal discs stop cell proliferation and differentiate: using nutrients accumulated by 
the larva during the feeding period, they undergo metamorphosis to form the adult fly. 
Among all the imaginal discs, the wing disc has been extensively used as a model to 
study tissue growth: easy to dissect, it grows by more than a thousand-fold during its 
development, following a very precise sequence of signaling events that coordinate 
tissue patterning and tissue growth. 
1.2.1  Wing disc development: coordination of patterning and growth 
The wing imaginal disc derives from an epithelial monolayer that invaginates from the 
embryonic ectoderm between parasegments 4 and 5. It grows from approximately 20 
cells to 50 000 cells during the three larval stages until metamorphosis, when it 
generates the adult wing and half of the notum. The wing disc is composed of 3 
regions (Fig 1.3 B): the blade region, the hinge region, and a region that gives rise to 
half of the notum. The centre of the blade region is the presumptive distal part of the 
wing. The wing fate is specified by expression of the wingless gene while expression of 
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the EGFR (Epidermal Growth Factor Receptor) ligand Vein specifies the notum, and the 
2 domains are established through mutual antagonistic regulation between wingless 
signaling and EGFR signaling (Ng et al., 1996; Simcox et al., 1996; Wang et al., 2000).  
Early in development, the action of selector genes subdivides the wing disc into fields 
of cells called compartments, separated by two straight boundaries of lineage 
restriction: the antero-posterior (AP) boundary and the dorso-ventral (DV) boundary 
(Vincent, 1998). Cells from each compartment have distinct adhesive properties and 
do not mix with each other. Growth and patterning of the wing disc are tightly linked 
and are coordinated by signals emanating from the AP and DV boundaries (Fig 1.4) 
(Klein, 2001).  
 The wing disc inherits expression of the engrailed (en) selector gene from the 
embryonic parasegment boundary it arises from, which specifies posterior fate and the 
antero-posterior boundary. en activates the expression of hedgehog (hh) ligand, which 
acts as a short-range morphogen and activates the expression of decapentaplegic 
(dpp) (Basler and Struhl, 1994). Cells from the posterior compartment are not 
receptive to hh signaling. Thus, hh triggers the expression of dpp in a narrow stripe in 
the anterior compartment along the antero-posterior boundary. Dpp is a protein of the 
BMP/TGFβ family that acts as a long-range morphogen to promote patterning and 
differentiation of the wing in a medial-to-lateral direction, inducing the expression of 
target genes such as spalt (sal) and optomotor-blind (omb) in a concentration 
dependant manner (Affolter and Basler, 2007; Schwank and Basler, 2010). Activation 
of target genes at different positions in the wing field by hh and dpp signaling leads to 
the formation of wing veins L2 to L5 (Fig 1.3 B) at specific positions in the wing blade, 
in a process involving EGFR signaling (Crozatier et al., 2004; Sturtevant and Bier, 
1995). In addition, the Dpp gradient promotes uniform tissue growth (Affolter and 
Basler, 2007). 
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Figure 1.3: Drosophila development 
(A) Drosophila life cycle. Source: http://flymove.uni-muenster.de; (B) Imaginal discs of the 
Drosophila third instar larva. The wing disc gives rise to the adult wing, the wing disc pouch gives 
rise to the wing blade, its centre being the future distal part of the wing, and the wing disc 
proximal region gives rise to the hinge and half the notum (figure from Pedro Gaspar, modified 
with his permission).  
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Figure 1.4: Wg and Dpp morphogen gradients in the wing imaginal disc 
The action of the apterous (ap) and engrailed (en) selector genes sets the antero-posterior and 
dorso-ventral boundaries expressing the decapentaplegic (dpp) and wingless (wg) morphogens 
that diffuse from their source to control patterning and growth of the wing.   
 
Shortly after hatching of the larva, Vein activates expression in the dorsal 
compartment of the selector gene apterous (ap) (Wang et al., 2000), a transcription 
factor which specifies dorsal fate and the dorso-ventral boundary (Blair et al., 1994; 
Diaz-Benjumea and Cohen, 1993). ap activates the expression of Notch pathway 
components. Notch signaling is activated specifically at the dorso-ventral boundary and 
initiates the expression of target genes such as wingless (wg) and vestigial in a narrow 
stripe along the DV boundary. Wg behaves as a long-range morphogen, diffusing from 
its source along the antero-posterior axis and acting as an organizer to promote tissue 
growth in the proximo distal axis (Diaz-Benjumea and Cohen, 1995). Vestigial (Vg) is a 
transcriptional co-activator that specifies the wing blade with its binding partner, the 
transcription factor Scalloped (Sd) (Halder et al., 1998). Vg domain of expression is 
expanded by a regulatory mechanism involving the combined activity of Vg itself, Dpp, 
which diffuses from the AP boundary, and Wg, which diffuses from the DV boundary 
(Zecca and Struhl, 2007a; Zecca and Struhl, 2007b). Wg is also expressed in two 
concentric rings in the proximal region of the wing disc, the future wing hinge. The 
wing hinge is specified by the expression of two transcription factors and binding 
partners: Homothorax (Hth) and Teashirt (Tsh). hth/tsh and vg mutually antagonise 
each other and their expression is restricted to the hinge region and to the blade 
region respectively (Azpiazu and Morata, 2000; Casares and Mann, 2000).  
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Thus, a hierarchy of selector genes specifies compartments of the wing disc and set up 
the AP and DV organizers expressing the long-range morphogens Dpp and Wg 
respectively. Dpp and Wg then promote wing growth and patterning in a coordinated 
manner.  
1.2.2  Tissue growth effectors  
The link between developmental programs and regulators of tissue growth is still poorly 
understood. Clearly, wing growth proceeds by cell proliferation, so developmental 
signals and transcription factors must control the cell proliferation machinery. In 
Drosophila, the rate-limiting G1-S cell cycle regulator is Cyclin E (CycE), which acts with 
Cdk2, and the rate limiting G2-M cell cycle regulator is cdc25/String (Stg), an activator 
of cyclinB/Cdk1 complexes. In the wing disc, overexpression of CycE and Cdc25/String 
or the E2F1/Dp transcription factor complex, which activates the transcription of cell 
cycle genes including CycE and Stg, leads to an increase in the rate of cell division 
(Neufeld et al., 1998). Interestingly, this increase in cell division does not result in 
overgrowth, but in a tissue of a relatively normal size containing an increased number 
of cells smaller than normal. On the contrary, slowing or arresting the cell cycle by 
using Cdc2 mutations or overexpressing RBF, an E2F1 inhibitor, results in a tissue 
composed of fewer but bigger cells (Fig 1.5) (Neufeld et al., 1998; Weigmann et al., 
1997). Thus, in order to control tissue growth, developmental signals need to regulate 
both cell growth and cell division rates. In addition, these experiments show that the 
developmental program does not measure cell number but rather absolute tissue size.  
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Control of cell growth 
In order to increase its volume, a cell needs to increase the amount of proteins it 
produces. Thus, regulation of protein synthesis rates is critical for cell growth. Genes 
essential for cell growth include genes related to protein synthesis like the ribosomal 
proteins Minutes, translation and elongation factors, and factors involved in ribosome 
biogenesis. One particularly interesting one is the transcription factor dmyc, a potent 
dose dependent regulator of cell growth (Bellosta and Gallant, 2010). It activates the 
transcription of several genes involved in protein synthesis and dmyc overexpression 
results in abnormally large cells. Moreover, dmyc expression is not ubiquitous but 
follows a pattern. Therefore, it is probably a key effector targeted by developmental 
signaling pathways to control growth. Cell growth is also controlled by the Insulin/TOR 
signaling pathway. In response to nutrient intake, insulin-like peptides (dILPs) are 
secreted by the gut and neurosecretory cells in the brain, and activate the Insulin 
Receptor (InR) in different tissues. The InR activates a signaling cascade that leads to 
the activation of ribosome biogenesis (Hietakangas and Cohen, 2009). Thus, Insulin 
signaling allows tissues to coordinate their growth in function of nutritional conditions. 
Loss of InR in the wing disc phenocopies starvation and results in small cells. 
Interestingly, patterning and cell proliferation scale with this input, resulting in smaller 
organs of the right proportions (Parker, 2011). Other endocrine factors affect cell 
Figure 1.5: Uncoupling of cell 
growth and cell division in the 
Drosophila wing disc 
Nuclear staining in Drosophila wing 
discs. A-B: control wing disc; C-D: Over-
expression of E2F/DP in the posterior 
compartment accelerates the cell cycle 
progression thereby increasing the 
number of cells as shown by the 
increase in nuclei density. E-F: Over-
expression of RBF delays cell cycle 
progression, resulting in a reduction in 
cell number and an increase in cell size, 
as shown by the reduced density of 
nuclei. 
Figure from (Neufeld et al., 1998) 
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growth such as ecdysone, Juvenile Hormone (JH) and Imaginal disc growth factors 
(IDGFs). 
Control of cell proliferation: the sum of cell growth and cell division 
Different factors have been shown to control cell proliferation including Cyclin D/Cdk4, 
which promotes both cell growth and cell cycle progression (Datar et al., 2000), and 
the bantam microRNA, which promotes cell proliferation and inhibits apoptosis (Hipfner 
et al., 2002). bantam was shown to downregulate the apoptotic gene hid (Brennecke 
et al., 2003) and the myc negative regulator mei-P26 (Herranz et al., 2010), but is 
also predicted to target more genes controlling cell proliferation. Interestingly, bantam 
expression is higher in proliferating tissues, indicating it may be controlled by pathways 
regulating cell proliferation. Indeed, bantam microRNA was identified as a target of the 
Hippo growth control pathway (Thompson and Cohen, 2006). In addition to those 
downstream regulators, mutagenic screens have uncovered several tumor suppressor 
genes essential to control cell proliferation (Watson et al., 1994), and have led to the 
discovery of a key cell proliferation control pathway: the Hippo signaling pathway, 
which I will describe in the next section.  
1.3 The Hippo signaling pathway 
In the last decade, new light has been shed on growth control from the discovery of 
the Hippo signaling pathway (Halder and Johnson, 2011; Harvey and Tapon, 2007; 
Zhao et al., 2010a). All developmental signaling pathways known to affect tissue 
growth also affect other processes such as patterning and differentiation. The Hippo 
signaling pathway is a unique pathway in that it is mainly dedicated to tissue growth 
control. Moreover, it is the first pathway that was shown to regulate both cell 
proliferation and cell survival. This conserved pathway was discovered in Drosophila 
where its core components, such as the upstream kinase Hippo (Hpo) and the 
downstream kinase Warts (Wts) are strong tumour suppressors. Mutations in any of 
those components lead to massive tissue overgrowth (Fig 1.6). Thus, Hippo signaling is 
required during development to restrict tissue growth and allow organs to reach their 
correct size.  
Chapter 1. Introduction 
 23 
1.3.1  Core components  
The key effector of Hippo signaling is the transcriptional co-activator Yorkie (Yki), 
which activates the expression of target genes that promote cell proliferation and cell 
survival such as cyclin E (cycE) and Drosophila inhibitor of apoptosis 1 (DIAP1) (Huang 
et al., 2005). Yki is a dose dependent regulator of tissue growth: mutations in yki 
result in strong undergrowth, while overexpression of yki triggers massive 
overproliferation (Fig 1.7 A-C’). Yki is regulated by a cascade of phosphorylations 
involving the upstream kinase Hpo, a member of the Ste20 (sterile20)-like family of 
serine/threonine kinases, and the downstream kinase Wts, an NDR (nuclear Dbf2-
related) serine/threonine kinase (Fig 1.8) (Harvey et al., 2003; Jia et al., 2003; Justice 
et al., 1995; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003; Xu et al., 
1995). 
Activation of the kinase cascade is not well understood, but requires phosphorylation 
of one of Hpo tyrosine residues (Tyrosine 195) in its activation loop (Colombani et al., 
2006; Polesello et al., 2006), possibly via auto-phosphorylation or phosphorylation by 
an unknown kinase (Genevet and Tapon, 2011; Pantalacci et al., 2003). Activated Hpo 
binds to and phosphorylates its co-factor Salvador (Sav), which stimulates Hpo to 
phosphorylate the downstream kinase Wts (Kango-Singh et al., 2002; Tapon et al., 
2002; Wu et al., 2003). In addition to phosphorylating Wts, Hpo phosphorylates the 
Wts co-factor Mob as a tumor suppressor (Mats), promoting its association with Wts. 
Phosphorylation of Wts by Hpo and association with its co-factor Mats activates Wts 
catalytic domain (Lai et al., 2005). This complex cascade of phosphorylations thus 
leads to the activation of Wts, which in turn phosphorylates its target Yki on 3 
conserved serine residues (serines 111, 168 and 250)(Huang et al., 2005; Oh and 
Irvine, 2009). Yki phosphorylation on S168 promotes its binding to 14-3-3 proteins 
which sequester Yki in the cytoplasm, preventing it from activating its target genes 
(Dong et al., 2007). Mutations in all components of the kinase cascade in imaginal discs 
lead to massive overgrowth due to an important increase in cell proliferation and 
reduced levels of apoptosis. 
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Figure 1.6: Loss of Wts leads to a strong overgrowth phenotype 
Scanning Electron Micrographs of adult flies: top view of a wild type Drosophila head (left), and a 
Drosophila head with overgrown wts homozygous mutant eyes (right). 
 
 
 
Figure 1.7: Yki is a conserved dose dependent regulator of tissue growth  
(A) Over-expression of Yki in the Drosophila wing disc leads to dramatic overgrowth compared to 
a wild type wing disc (bottom left). Image from (Huang et al., 2005). (B-C’) Scanning Electron 
Micrographs from (Huang et al., 2005): eyes lacking yki (C, top view ; C’, lateral view) are 
dramatically undergrown compared to wild type (B, top view ; B’, lateral view). (D) Over-
expression of Yki homologue YAP in the mouse liver leads to a massive tissue overgrowth (right) 
compared to control (left). Image from (Dong et al., 2007). (E) YAP homozygous mutant mice 
embryos (right) are much smaller than their wild type siblings (left). Images from (Morin-Kensicki 
et al., 2006). 
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Figure 1.8: Schematics of the Hippo signaling pathway in Drosophila 
Plasma membrane and nucleus are outlined in black with adherens junctions (AJ) and septate 
junctions (SJ) represented by grey boxes. The kinase cascade is represented in green, Yki in red, 
and Yki nuclear partners in purple. Positive regulators of the kinase cascade are represented in 
orange, negative regulators are represented in blue. 
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All the core components of the Hpo pathway are conserved in mammals. MST1/2 (Hpo 
homologues), SAV1 (Sav homologue), LATS1/2 (Wts homologues), and MOBKL1A/B 
(Mats homologues), form a kinase cascade like their Drosophila counterparts and 
phosphorylate YAP and TAZ (Yki homologues), promoting their cytoplasmic retention 
by 14-3-3 proteins (Zeng and Hong, 2008; Zhao et al., 2007). One additional 
mechanism has been described: in mammals, phosphorylation of YAP and TAZ by 
LATS1/2 not only promotes their binding to 14-3-3 but also promotes their 
subsequent phosphorylation by another kinase, promoting their binding to SCFβTRCP E3 
ubiquitin ligase which triggers their degradation (Dong et al., 2007; Liu et al., 2010; 
Zhao et al., 2010b). Hippo pathway function in organ size control is conserved in 
mammals. YAP is essential for growth of mice embryos and YAP overexpression or 
conditional knock-outs of MST or NF2 in mice liver leads to massive tissue overgrowth 
and tumourigenesis (Fig 1.7 D, E) (Camargo et al., 2007; Dong et al., 2007; Song et 
al., 2010; Zhang et al., 2010). In addition, YAP is found strongly expressed and nuclear 
in many human tumours (Dong et al., 2007; Steinhardt et al., 2008), and levels of 
expression of other components of the pathway are affected in several human cancers 
(Pan, 2010).  
Although the core components of the Hippo signalling pathway are known and their 
biochemical interactions and functions have been well-characterised, upstream 
activation of the pathway as well as its downstream effects are poorly understood. 
Some of the upstream components have been identified in genetic interaction 
experiments but their exact biochemical mechanisms are not known. These 
components will be described in the following paragraphs.  
1.3.2  Kibra/Expanded/Merlin complex 
One key upstream regulatory component of Hippo signaling is the 
Kibra/Expanded/Merlin (Kibra/Ex/Mer) complex. Mutations in these components lead to 
moderate overgrowth phenotypes. Mer and Ex both contain a FERM domain: an F-actin 
binding domain found in proteins that link the actin cytoskeleton and the plasma 
membrane such as 4.1, ezrin, radixin and moesin, after which the FERM domain was 
named (Chishti et al., 1998). Mer and Ex both localise at the cell cortex and colocalise 
with Kibra at the sub-apical region of epithelial cells (Genevet et al., 2010; McCartney 
et al., 2000). Kibra, Mer and Ex bind to each other and act genetically upstream of 
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Hpo. The Kibra/Ex/Mer complex binds directly Hpo and Sav – via multiple interactions 
between Ex and Hpo, Mer and Sav, and Kibra and Sav – and promotes Hpo activity 
through an unknown mechanism (Baumgartner et al., 2010; Genevet et al., 2010; 
Hamaratoglu et al., 2006; McCartney et al., 2000; Yu et al., 2010). Mutants of kibra, 
ex or mer present tissue specific differences in phenotype severity, reflecting tissue 
specific requirements (Genevet et al., 2010; Pellock et al., 2007). Although single 
mutants for ex, mer and kibra show weak overgrowth phenotypes, double mutant 
combinations of ex, mer and kibra present more severe phenotypes, similar to those of 
hpo, sav, mats and wts mutants (Hamaratoglu et al., 2006; Yu et al., 2010). Thus, 
kibra, ex and mer act semi-redundantly to promote Hippo signaling.  
Human KIBRA, NF2/Merlin (Merlin human homolog) and Willin/FRMD6 (Expanded human 
homolog) all stimulate Hippo signaling and affect YAP activity in human cell lines: their 
function in Hippo signaling is conserved (Angus et al., 2011; Xiao et al., 2011; Yu et 
al., 2010; Zhang et al., 2010). FRMD6 binding to KIBRA and NF2 has not been 
investigated, but KIBRA and NF2 bind to each other, indicating they may act in a 
complex like their Drosophila homologues (Zhang et al., 2010).  
1.3.3  Phosphorylation independent regulation of Yki 
Yki contains 2 WW domains in its C terminal part, which can associate with PPXY motifs 
in other proteins to mediate direct binding. In addition to regulating Yki through Hippo 
signaling, Ex directly binds Yki via an interaction between its PPXY motifs and Yki WW 
domains. This binding can lead to Yki cytoplasmic retention in a phosphorylation 
independent manner (Badouel et al., 2009; Oh et al., 2009). Hpo and Wts contain PPXY 
motifs too and they are also able to sequester Yki in the cytoplasm by binding its WW 
domains. Expression of Hpo or Wts is able to suppress the nuclear localisation of a non-
phosphorylatable form of Yki in the eye disc, showing that Hpo and Wts can regulate 
Yki in a phosphorylation independent manner. However, these experiments have been 
carried out in non-physiological conditions as they involved overexpression of Ex, Hpo 
or Wts. The physiological significance of this phosphorylation independent effect on 
the regulation of Yki localisation has not been proven. A similar mode of regulation was 
suggested in human cells with Angiomotin family proteins. These junctional proteins 
directly bind YAP and TAZ, promoting their junctional localisation and preventing their 
nuclear localisation (Zhao et al., 2011). Another phosphorylation independent 
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mechanism, yet not clearly understood, is the negative regulation of Yki by the 
endosomal protein Myopic (Mop). Mop binds Yki WW domains through its PPXY motif 
and appears to affect Yki association with specific endosomal compartments (Gilbert et 
al., 2011).  
1.3.4  Fat/Hippo signaling  
The first transmembrane protein found to regulate Hippo signaling was the 
protocadherin Fat (Ft), which localises at the subapical-region of cells (Bennett and 
Harvey, 2006; Cho et al., 2006; Silva et al., 2006; Willecke et al., 2006). Drosophila fat 
mutant tissues present strong overgrowth phenotypes and perturbations in bristle 
orientation (Bryant et al., 1988; Mahoney et al., 1991). Fat is a well-known regulator of 
planar cell polarity (PCP), which is the mechanism that orients cellular structures such 
as hairs within the plane of a tissue (Axelrod, 2009). PCP is regulated by molecular 
complexes that localise in a planar polarised manner within cells. fat mutant overgrowth 
phenotypes, but not planar cell polarity (PCP) defects, can be rescued by wts 
overexpression. Thus, Fat regulates the establishment of PCP and restricts tissue 
growth via two independent pathways (Feng and Irvine, 2007). Fat regulates tissue 
growth by feeding into the Hippo pathway at 2 levels. First, it promotes the membrane 
localisation of Ex, thereby promoting Hpo activation (Bennett and Harvey, 2006; Silva 
et al., 2006; Willecke et al., 2006). In addition, Fat negatively regulates the 
unconventional myosin Dachs (D) (Cho and Irvine, 2004). In the wing disc, Dachs is 
present in the cytoplasm but localises preferentially at the apical cell cortex, where Wts 
is presumably activated by the Kibra/Ex/Mer complex (Mao et al., 2006), and this 
membrane localisation requires the palmitoyltransferase Approximated (App) 
(Matakatsu and Blair, 2008). Dachs binds to the LIM domain containing protein Zyxin 
(Zyx), an adherens junction localised protein, and promotes its binding to Wts, which 
leads to Wts degradation through an unknown mechanism (Cho et al., 2006; Rauskolb 
et al., 2011). In fat mutant cells, Dachs accumulates at the membrane, whereas in cells 
overexpressing fat, Dachs is mostly cytoplasmic. Thus, Fat antagonises Dachs by 
inhibiting its membrane localisation (Cho et al., 2006). The level of Fat at the 
membrane is regulated by the protein Lowfat (Lft), which interacts with Fat 
intracellular domain (Mao et al., 2009). Fat activation is regulated by its ligand, the 
protocadherin Dachsous (Ds), and by the serine/threonine kinase Disc overgrown (Dco) 
Chapter 1. Introduction 
 29 
which activates Fat by promoting its intracellular domain phosphorylation in a Ds 
dependent manner (Clark et al., 1995; Feng and Irvine, 2009; Sopko et al., 2009; 
Willecke et al., 2008). Fat and Ds form trans-heterodimers and their interaction is 
modulated by the Golgi kinase Four-jointed (Fj) which phosphorylates their cadherin 
domains: Fat phosphorylation by Fj increases Fat affinity for Ds, while Ds 
phosphorylation by Fj decreases Ds affinity for Fat (Brittle et al., 2010; Ishikawa et al., 
2008; Simon et al., 2010).  
Dachsous and Four-jointed are expressed in two opposite gradients along the proximo-
distal axis of Drosophila imaginal discs: with Ds higher expression in the proximal region, 
and Fj higher expression in the distal region (Brodsky and Steller, 1996; Clark et al., 
1995; Villano and Katz, 1995). These gradients modulate the amount of Ds binding to 
Fat and result in the enrichment of Ds-bound (active) Fat at the proximal side of the 
cells thereby restricting Dachs membrane localisation to the distal side (Mao et al., 
2006). This planar polarisation of Fat activity is involved in the establishment of PCP. In 
addition to regulating PCP, graded expression of fj and ds leads to partial inactivation 
of Fat signaling thereby restricting Hippo signaling and promoting tissue growth. 
Restriction of Dachs activity to the distal side of cells was also shown to be important 
for controlling shape in the wing by promoting the orientation of cell divisions along the 
proximo-distal axis (Mao et al., 2011b). Interestingly, fj and ds expression is influenced 
by Dpp and Wg signaling, providing a potential link between upstream developmental 
signals and coordination of planar cell polarity, tissue shape, and tissue growth control 
by Hippo signaling (Lawrence et al., 2008; Rogulja et al., 2008; Zecca and Struhl, 
2010).  
Fat and Ds homologues are Fat4 and Dchs1. Mutant mice for these 2 genes present 
PCP and organ shape defects but no obvious defects in organ size (Mao et al., 2011a; 
Saburi et al., 2008), indicating that other homologues may accomplish Fat/Ds signaling 
function in growth control, or that there may be some redundancy among paralogues.   
1.3.5  Lgl, aPKC and Crumbs 
Recently, the regulators of apico-basal polarity Lgl (Lethal giant larvae), aPKC (atypical 
Protein Kinase C) and Crumbs have been linked to Hippo signaling. The apical 
determinant aPKC inhibits Hippo signaling by reducing Hpo apical localisation and 
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promoting Hpo colocalisation with its negative regulator RASSF. The protein RASSF is 
an inhibitor of Hpo that competes with Sav for binding to Hpo, and recruits the protein 
phosphatase 2A (PP2A) complex STRIPAK (Striatin-interacting phosphatase and 
kinase), which de-phosphorylates and thus inactivates Hpo (Polesello et al., 2006; 
Ribeiro et al., 2010). aPKC function is antagonised by the basal determinant Lgl, which 
promotes Hippo signaling (Grzeschik et al., 2010). Crumbs (Crb) is a transmembrane 
protein that localises at the sub-apical region of epithelial cells and regulates apico-
basal polarity in embryonic epithelia but not in imaginal discs. In imaginal discs, loss of 
crb causes overgrowth and Yki dependent Hippo pathway target genes up-regulation 
(Chen et al., 2010; Ling et al., 2010; Richardson and Pichaud, 2010; Robinson et al., 
2010). Crb binds Ex through its FERM binding domain and promotes Ex apical 
localisation (Chen et al., 2010; Ling et al., 2010; Robinson et al., 2010). Clones of cells 
mutant for crb loose Ex apical localisation. Interestingly, adjacent cells also loose apical 
localisation of Crb and Ex specifically at the junction with crb mutant cells, possibly 
because Crb needs to trans-homodimerise to be stable at the membrane (Chen et al., 
2010). Thus, Crb may be involved in cell-cell contact inhibition (cf paragraph 1.3.6).  
Crb homologue CRB3 was also shown to affect Hippo signaling in cell cultures and 
mouse embryos (Varelas et al., 2010).  
1.3.6  Hippo signaling: from the cell cortex to the nucleus  
In recent years, a new view of Hippo signaling has emerged. Many components of Hippo 
signaling are localised apically, at cell junctions, or associated with the actin 
cytoskeleton. Localisation of the Hpo kinase cassette at the apical cortex appears to 
be important for efficient activation of the pathway, and it has been proposed that 
Hippo signaling senses molecular and mechanical cues from neighbouring cells at the 
apical cell cortex and at cell-cell junctions, and responds by changes in gene expression 
through regulation of Yki/YAP/TAZ (reviewed by (Genevet and Tapon, 2011)). In 
mammalian cell lines, Hippo signaling is involved in contact inhibition of cell proliferation 
(Ota and Sasaki, 2008; Zhao et al., 2007). Contact inhibition is a phenomenon by which 
cells stop proliferating once they have reached confluence. This property is 
characteristic of differentiated cells in normal tissues and loss of contact inhibition 
leads to tumour formation (Fagotto and Gumbiner, 1996). At low cell density, YAP 
localises predominantly in the nucleus and drives cell proliferation with its partner TEAD 
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(Ota and Sasaki, 2008; Zhao et al., 2007). By contrast, at high cell density, YAP is 
phosphorylated by LATS1/2 and translocates to the cytoplasm (Zhao et al., 2007). 
Although the mechanism of Hippo signaling activation upon cell contact inhibition 
remains elusive, the link between cell adhesion molecules mediating cell contact 
inhibition and Hippo signaling is starting to be unravelled. Recently, Hippo pathway 
dependent cell contact inhibition was shown to be regulated by the adherens junction 
proteins E-cadherin, α-catenin and β-catenin (Kim et al., 2011), and by the tight 
junction Crumbs complex, which includes Angiomotin family proteins (Varelas et al., 
2010; Zhao et al., 2011). Interestingly, in Drosophila, 2 adherens junction proteins 
have been shown to affect Hippo signaling: Zyxin, described above, and Ajuba, which 
negatively regulates Wts kinase activity by an unknown mechanism (Das Thakur et al., 
2010; Rauskolb et al., 2011). Considering the role of junction proteins in cell contact 
inhibition in human cells, and considering the role of zyxin and ajuba in controlling cell 
proliferation, these proteins could be involved in cell contact inhibition in Drosophila 
tissues. 
Another important role for Hippo signaling was recently discovered in 
mechanotransduction (Dupont et al., 2011; Wada et al., 2011). Mechanotransduction 
is the translation of a mechanical stimulus, such as cell compression or cell stretching, 
into a biological response such as cell proliferation or differentiation. Both Dupont et al 
and Wada et al show that YAP/TAZ localisation responds to the degree of cell 
spreading: YAP/TAZ are more nuclear in isolated cells that occupy a large area than in 
isolated cells that are more compact. They also show that spread cells produce more 
actin stress fibers than compact cells and that experimental induction of stress fibre 
formation promotes YAP/TAZ nuclear translocation. Moreover, Dupont et al show that 
inhibition of ROCK and non-muscle myosin – which are required to generate cytoskeletal 
tension – prevents YAP/TAZ nuclear localisation. Therefore, nuclear translocation of 
YAP/TAZ upon cell spreading is dependent on tensile forces generated by actin stress 
fibres. The involvement of upstream Hippo pathway components is unclear, and the 
molecular mechanism of this regulation is not elucidated, but the role of F-actin on 
Hippo pathway regulation was also shown in Drosophila, where experimental induction 
of actin stress fibres in wing imaginal discs leads to strong overgrowth, Yki nuclear 
translocation and upregulation of Hippo pathway target genes in a Yki dependent 
manner (Fernández et al., 2011; Sansores-Garcia et al., 2011).  
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1.3.7  Yki regulation, partners and targets 
From multiple upstream inputs, Hippo signaling converges on the transcriptional co-
activator Yki. Mutations in yki completely suppress the overgrowth phenotype of hpo, 
wts or sav mutant clones and yki overexpression in the wing or eye causes strong 
tissue overgrowth (Huang et al., 2005). Known Yki target genes include the cell 
proliferation genes cycE (Huang et al., 2005), E2F1 (Goulev et al., 2008), bantam 
microRNA (Nolo et al., 2006; Thompson and Cohen, 2006), and myc (Neto-Silva et al., 
2010), the anti-apoptotic gene DIAP1 (Huang et al., 2005), and upstream Hippo 
pathway regulators kibra, ex, mer, fj and crb (Cho et al., 2006; Genevet et al., 2009; 
Genevet et al., 2010; Hamaratoglu et al., 2006), providing a negative feedback 
mechanism. Direct association of Yki to target gene promoters has been shown for 
bantam (Peng et al., 2009), myc (Neto-Silva et al., 2010) and DIAP1 (Wu et al., 2008). 
In some developmental contexts, Hippo signaling also affects the expression of 
signaling molecules such as the Wnt signaling ligand wg (in the wing disc inner ring of 
wg expression), the Notch ligands delta (in the adult gut) and serrate (in the leg disc) 
and the JAK-STAT ligands unpaired (upd) 1/2/3 (in the adult gut) (Cho et al., 2006; 
Shaw et al., 2010).  
Very little is known about the mechanism of activation of Hippo pathway target genes. 
Yki does not contain a DNA binding domain and must therefore associate with 
transcription factors to activate its target genes. The first transcription factor 
identified as a crucial partner for Yki was the TEF/TEAD family protein Scalloped, which 
binds a conserved domain in Yki N-terminal region (Goulev et al., 2008; Wu et al., 
2008; Zhang et al., 2008). The role of Sd in Yki target gene activation is conserved in 
mammals, where TEAD transcription factors bind YAP/TAZ and are required for the 
expression of YAP/TAZ target genes (Zhang et al., 2009a; Zhao et al., 2008). In 
Drosophila, Sd recruits Yki to the DNA, and in addition promotes Yki nuclear localisation 
both in cell culture and in Drosophila tissues. In the wing and eye imaginal discs, 
mutations in sd suppress the overgrowth phenotype and target gene upregulation 
caused by yki overexpression. Thus, Sd is required for Yki to promote target gene 
expression and growth. However, there is plenty of evidence that Yki needs to interact 
with other DNA binding factors to activate its target genes. Indeed, yki is required for 
normal growth in all of the imaginal tissues (Huang et al., 2005) but sd is not 
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ubiquitously expressed and seems specifically required for cell proliferation in the wing 
(Campbell et al., 1992). Whereas yki mutant clones are strongly undergrown in all 
imaginal tissues, sd mutant clones are small in the wing blade region but grow normally 
in the eye disc (Peng et al., 2009; Wu et al., 2008). Two non-mutually exclusive 
hypothesis explain the discrepancy between yki and sd phenotypes:  
1. Default repression: Sd may act as a transcriptional activator in the presence of Yki, 
and as a transcriptional repressor in the absence of Yki. Thus, target genes in sd 
mutant clones would lack Yki activation but also Sd repression, which would 
produce an intermediate phenotype. Consistent with this hypothesis is the fact that 
overexpression of Sd alone in the wing or in the eye causes tissue undergrowth, 
whereas overexpression of Sd with Yki strongly enhances Yki overgrowth phenotype 
(Wu et al., 2008).   
2.  Binding of Yki to other transcription factors: as Sd is not expressed ubiquitously, 
Yki needs other transcription factors to bind DNA and ensure target gene activation 
in tissues where Sd is not expressed such as the anterior eye disc (Campbell et al., 
1992). Indeed, the transcription factor Homothorax (Hth) was identified as a Yki 
partner in that tissue (Peng et al., 2009). Specification of the eye occurs as a wave 
of differentiation, or morphogenetic furrow (MF), sweeps across the eye disc 
epithelium from the posterior to the anterior. Cells anterior to the MF proliferate to 
provide a sufficient number of progenitor cells to form a functional eye, while cells 
posterior to the MF stop proliferating and start to differentiate to produce 
photoreceptors. Later during eye development, a second mitotic wave occurs in 
undifferentiated cells posterior to the MF. Homothorax (Hth) and its binding partner 
Teashirt (Tsh) are expressed anterior to the MF, where they inhibit premature 
differentiation. Yki associates with Hth/Tsh at bantam promoter and activates 
bantam expression, thereby promoting cell proliferation.  Interestingly, Sd is 
expressed posterior to the morphogenetic furrow (Campbell et al., 1992), and may 
therefore be involved in Yki target gene activation posterior to the furrow. 
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Yki can also cooperate with other transcription factors that bind to the same 
promoters to drive target gene expression. Indeed, Wu et al have identified a Hippo 
pathway Responsive Element (HRE), a minimal sequence of 26 base pair upstream of 
DIAP1 that is necessary and sufficient for DIAP1 induction upon Yki activation. HRE 
contains a 7-nucleotide Sd binding motif, but the other 19 nucleotides are as essential 
as the Sd binding motif for target gene expression, indicating that there are other 
factors binding to the HRE, necessary for Yki activity.  
Recently, Yki was shown to bind the bantam regulatory region with Mad, the 
transcription factor regulated by Dpp signaling, and to promote bantam expression (Oh 
and Irvine, 2011). Thus, although they control different sets of genes, Mad and Yki 
cooperate to activate a common set of target genes. This link between Hippo and TGFβ 
signaling is conserved in mammals where YAP and TAZ associate with different Smad 
transcription factors, although the precise role of these interactions in growth control 
by Hippo signaling remains to be determined (Alarcón et al., 2009; Ferrigno et al., 
2002; Varelas et al., 2008). Cooperativity was also described between Yki and E2F1, 
which share a common set of target genes (Nicolay et al., 2011). 
In addition to cooperating with different transcription factors, Yki recruits 
transcriptional co-activators. For instance, the Yki WW domains are important for Yki 
repression, but are also essential for Yki’s transactivator function in the nucleus. 
Recently, the conserved protein Wbp2 was found to bind to Yki’s WW domains and to 
promote Yki target gene expression when overexpressed in both Drosophila and human 
Figure 1.9: Schematics of the 
differentiating eye imaginal disc  
The morphogenetic furrow (MF) sweeps 
the eye disc from posterior (P) to 
anterior (A). Progenitor cells proliferate 
until they are met by the MF. Cells 
posterior to the furrow stop 
proliferating and differentiate into 
photoreceptor cells. Hth domain of 
expression is represented in green, Sd 
domain of expression is represented in 
yellow.  
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cells (Chan et al., 2011; Chen et al., 1997; Zhang et al., 2011b). However, 
identification of more Yki partners is needed in order to better understand how Yki 
activates its target genes to promote tissue growth in different developmental 
contexts.  
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Chapter 2.  Materials and methods 
2.1 Drosophila genetics 
2.1.1  GAL4/UAS system 
The GAL4/UAS system is a powerful genetic tool used to label specific cells or tissues 
or to overexpress genes in a particular tissue to study their phenotypes (Brand and 
Perrimon, 1993). GAL4 is a yeast transcription factor that binds to a specific UAS 
(Upstream Activation Sequence) to activate its target genes. Expression of GAL4 in 
Drosophila cells has no effect as GAL4 specifically binds the UAS. A gene X can be 
cloned under the control of a UAS promoter and used to generate transgenic flies 
carrying a UAS.X sequence. This UAS.X transgenic line can be crossed to a transgenic 
line carrying a GAL4 construct under the control of a tissue specific promoter, 
producing flies carrying both constructs, therefore expressing gene X in that particular 
tissue (Fig 2.1). Several tissue-specific GAL4 lines are available, such as 
hedgehog.GAL4 (hh.GAL4) and MS1096.GAL4 used to express UAS transgenes in the 
posterior compartment of the wing and in the whole wing respectively, or eyeless.GAL4 
(ey.GAL4) and GMR.GAL4, used to express UAS transgenes in the eye.  
 
Figure 2.1: The GAL4/UAS system 
 
2.1.2  Generation of mitotic clones 
Mosaic tissues were generated using the FLP/FRT and the MARCM system with a heat 
shock promoter (hs) to drive the expression of the FLP recombinase. Clones were 
induced by heat shocking larvae at 84 hr (± 12 hr) of development and larvae were 
dissected at the third instar stage. 
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The FLP/FRT system is used to generate mitotic clones of homozygous mutant cells 
in a heterozygous mutant tissue (Harrison and Perrimon, 1993).  This genetic tool 
makes use of the yeast site-specific FLP recombinase, under the control of a heat 
shock-inducible promoter (hs), which catalyses recombination between FRT sequences 
(FLP Recombination Target). The system is described in Figure 2.2.  
A variant of the system is to use a tissue-specific promoter to induce FLP expression. 
For instance the ey.FLP transgene allows generation of clones in the eye. In this case, a 
w+ transgene can be used instead of the GFP to mark clones in adult eyes (in a white 
mutant background). Another variant is the FRT Minute system. When clones of cells 
with reduced viability are induced in a tissue, they are outcompeted by surrounding 
cells by a process called cell competition, proliferating very poorly and undergoing 
apoptosis. Thus, it is sometimes difficult to recover mutant clones for certain genes 
that strongly affect cell viability. The FRT Minute system allows recovery of bigger 
mutant clones for such genes. In addition to the GFP reporter, the chromosome arm 
carrying the wild type allele for the gene of interest also carries a mutation in a dose 
dependent regulator of growth, such as minute genes, which is homozygous lethal and 
gives a comparative advantage to the homozygous mutant clones that do not carry 
the minute mutation over heterozygous minute mutant cells. Using the FRT Minute 
system in combination with ey.FLP allows the generation of whole mutant eyes instead 
of mosaic eyes that would normally be obtained by using the classic ey.FLP/FRT 
system. 
The MARCM system is another elegant variant of the FLP/FRT system (Lee and Luo, 
1999). By contrast to the classical FLP/FRT system that marks mutant cells by the 
absence of GFP, the MARCM system allows positive labelling of mutant cells by GFP 
expression. This system is described in Figure 2.3.  
Clone size quantification: clone size was measured using the ImageJ software. 
Clone area was measured with a selection tool. For each genotype, the areas of 25-30 
clones were measured and averaged. Graphs were generated in Microsoft Excel.  
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Figure 2.2: The FLP/FRT system 
The pair of chromosomes containing the gene of interest x carries FRT transgenes near the 
centromeric region, on the same arm as gene x. One homologue of the pair contains a mutant 
allele xMUTANT, while the other chromosome bears the wild type allele xWT and a GFP reporter gene 
under the control of a ubiquitous promoter. Upon heat-shock, FLP is expressed and catalyses the 
recombination of FRT sequences between the 2 homologous chromosomes, producing 2 chimeric 
chromosomes, each carrying the 2 different alleles of gene x on its sister chromatids. During the 
next mitosis, sister chromatids segregate to daughter cells, producing 2 possible outcomes: 
1- One chromatid of each genotype moves to each daughter cell, resulting in two genetically 
identical daughter cells heterozygous mutant for gene x, and expressing 1 dose of GFP like other 
tissue cells. 2- the 2 chromatids that carry the xWT allele and the GFP transgene segregate in one 
daughter cell, producing a wild type cell expressing 2 doses of GFP; the 2 chromatids carrying 
xMUTANT allele segregate in the other daughter cell, resulting in a wild-type cell that does not 
express the GFP. These two daughter cells proliferate, forming twin clones of cells.  
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Figure 2.3: The MARCM system  
The MARCM system uses the same principle as the FLP/FRT system (Fig 2.2) but differs by 2 
points:  
1. A GAL4 transgene is ubiquitously expressed and all cells contain a UAS.GFP transgene. 
2. The FRT WT chromosome arm carries a GAL80 transgene instead of the GFP reporter. GAL80 
is an inhibitor that binds GAL4 and prevents GAL4 transactivation activity.  
Thus, all cells from the body express both GAL4 and GAL80, and are therefore unable to express 
the UAS.GFP transgene.  Only clones of homozygous mutant cells, which do not carry the GAL80 
transgene, can express the GFP.  
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2.1.3  Drosophila strains and genotypes 
Mask RNAi lines: VDRC GD 33394 , NIG-Fly 6313R2, NIG-Fly 6313R3 ; Wts RNAi line: 
VDRC GD 9928  ; Raf RNAi line: VDRC GD 2090 
Second hairpin RNAi lines ordered from NIG-fly are listed in Table 2 (Appendix) 
FRT82B mask 10.22, FRT82B mask 6.3 and FRT82B mask 7.29 were gifts from Michael 
Simon (Smith et al., 2002). UAS.YkiV5, UAS.YkiV5S168A and UAS.YkiV5S111A-S168A-S250A 
lines were gifts from K. Irvine (Oh and Irvine, 2009). All other fly strains are described 
in Flybase (Tweedie et al., 2009). 
Genotypes were as follows:  
Figure 4.1 A:  MS1096.GAL4/+ 
Figure 4.1 B:  MS1096.GAL4/+ ;; UAS.mask-IR(VDRC GD 33394)/+  
Figure 4.1 C:  ey.GAL4, GMR.GAL4/+  
Figure 4.1 D:  ey.GAL4, GMR.GAL4/+ ; UAS.mask-IR (NIG-fly 6313R2) /+ 
Figure 4.3 A:  yw, ey.flp/+ ;; FRT82B/FRT82B Minute w+  
Figure 4.3 B:  yw ey.flp/+ ;; FRT82B mask10.22/FRT82B Minute w+  
Figure 4.3 C:  yw, hs.flp/+ ;; FRT82B/FRT82B GFP  
Figures 4.3 D and 4.4: yw, hs.flp/+ ;; FRT82B mask10.22/FRT82B GFP  
Figure 4.5 A, C: w ;; hh.GAL4/+ 
Figure 4.5 B, D: w ;; hh.GAL4/P{EPgy2}EY01848 
Figure 4.6 A: w ;; hh.GAL4, UAS.DIAP1/+ 
Figure 4.6 B: w ;; hh.GAL4, UAS.DIAP1/ UAS.mask-IR (NIG-fly 6313R2) 
Figure 4.6 C: w ;; raf-IR(VDRC GD 2090) /+ ; hh.GAL4, UAS.DIAP1/+ 
Figure 4.6 D, D’: ey.GAL4, GMR.GAL4/+  
Figure 4.6 E, E’: ey.GAL4, GMR.GAL4/+ ; UAS.mask-IR(NIG-fly 6313R2) /+ 
Figure 4.6 F: yw,  ey.flp/+ ;; FRT82B mask10.22/FRT82B GFP  
Figure 4.7 A: MS1096.GAL4/+ 
Figure 4.7 B:  MS1096.GAL4/+ ;; UAS.wts-IR(VDRC GD 9928 )/+  
Figure 4.7 C:  ey.GAL4, GMR.GAL4/+ 
Figure 4.7 D, E: ey.GAL4, GMR.GAL4/+ ; UAS.wts-IR(VDRC GD 9928 )/+  
Figure 4.8 A,B: w ; fj.lacZ/+ ; hh.GAL4/+  
Figure 4.8 C:  w ; ex.LacZ /+ ; hh.GAL4, UAS.GFP/+  
Figure 4.8 D:  w ; en.GAL4, UAS.GFP /+ ; DIAP1.lacZ/+  
Figure 4.8 E,F: w ; fj.lacZ/mask-IR(NIG-fly 6313R3) ; hh.GAL4/+  
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Figure 4.8 G: w ; ex.LacZ / mask-IR(NIG-fly 6313R3)  ; hh.GAL4, UAS.GFP/+ 
Figure 4.8 H: w ; en.GAL4, UAS.GFP /mask-IR(NIG-fly 6313R3) ; DIAP1.lacZ/+ 
Figure 4.9 A, A’:  yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ; fj.lacZ/+ ;   
FRT82B mask10.22/FRT82B CD21 y+ GAL80    
Figure 4.9 B, B’:  yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ; ex.lacZ/+ ;  
FRT82B mask10.22/FRT82B CD21 y+ GAL80  
Figure 4.9 C, C’: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ; DIAP.lacZ,  
FRT82B mask10.22/FRT82B CD21 y+ GAL80  
Figure 4.12: w ; MyoIAGal4/+ ; tubGal80ts, UAS.GFP/+ (adult flies were shifted to 
restrictive temperature (29°C) to drive the UAS.GFP expression) 
Figure 4.13 A: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; FRT82B/ 
FRT82B CD21 y+ GAL80   
Figure 4.13 B:  yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; UAS.YkiV5, FRT82B/  
FRT82B CD21 y+ GAL80  
Figure 4.13 C: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; FRT82B mask10.22/ 
FRT82B CD21 y+ GAL80  
Figure 4.13 D: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; UAS.YkiV5,  
FRT82B mask10.22/FRT82B CD21 y+ GAL80  
Figure 4.14: (control) w ; FRT82B mask6.3 or7.29/ FRT82B.  (mask) w ;  
FRT82B mask6.3/ FRT82B mask7.29  
Figure 4.15 A: yw, ey.flp/+ ;; FRT82B/FRT82B Minute w+ 
Figure 4.15 B: yw ey.flp/+ ;; FRT82B mask10.22/FRT82B Minute w+ 
Figure 4.15 C: yw ey.flp/+ ;; FRT82B wtsX1/FRT82B Minute w+ 
Figure 4.15 D: yw ey.flp/+ ;; FRT82B mask10.22, wtsx1/FRT82B Minute w+ 
Figure 4.15 E: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; FRT82B/ 
FRT82B CD21 y+ GAL80 
Figure 4.15 F: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; FRT82B mask10.22/ 
FRT82B CD21 y+ GAL80  
Figure 4.15 G: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ; FRT82B wtsx1/ 
FRT82B CD21 y+ GAL80  
Figure 4.15 H: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; FRT82B mask10.22, wtsx1/ 
FRT82B CD21 y+ GAL80 ;  
Figure 4.16 A: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; FRT82B/ 
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FRT82B CD21 y+ GAL80   
Figure 4.16 B and 4.17 E, E’: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; UAS.YkiV5, 
FRT82B/ FRT82B CD21 y+ GAL80  
Figure 4.16 C: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; UAS.Yki S168AV5, FRT82B/  
FRT82B CD21 y+ GAL80  
Figure 4.16 D: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; UAS.Yki S111A-S168A-S250AV5, 
FRT82B/ FRT82B CD21 y+ GAL80  
Figure 4.16 E: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; FRT82B mask10.22/ 
FRT82B CD21 y+ GAL80  
Figure 4.16 F and 4.17 F, F’: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; UAS.YkiV5,  
FRT82B mask10.22/FRT82B CD21 y+ GAL80  
Figure 4.16 G: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; UAS.Yki S168AV5, FRT82B 
mask10.22/FRT82B CD21 y+ GAL80  
Figure 4.16 H: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; UAS.Yki S111A-S168A-S250AV5,  
FRT82B mask10.22/FRT82B CD21 y+ GAL80  
Figure 4.18 A, A’: yw, tub.GAL4, hs.flp, UAS nucGFP-myc ; ex.lacZ/+ ; FRT82B wtsx1/ 
FRT82B CD21 y+ GAL80   
Figure 4.18 B, B’: yw, tub.GAL4, hs.flp, UAS nucGFP-myc ; ex.lacZ/+ ;  
FRT82B mask10.22, wtsx1/FRT82B CD21 y+ GAL80 
Figure 4.18 C, C’: yw, tub.GAL4, hs.flp, UAS nucGFP-myc ; fj.lacZ/+ ;  
FRT82B mask10.22, wtsx1/FRT82B CD21 y+ GAL80 
Figure 4.19 A, A’: yw, tub.GAL4, hs.flp, UAS nucGFP-myc ; fj.lacZ/+ ; FRT82B wtsx1/ 
FRT82B CD21 y+ GAL80   
Figure 4.19 B, B’: yw, tub.GAL4, hs.flp, UAS nucGFP-myc ; fj.lacZ/+ ;  
FRT82B mask10.22, wtsx1/FRT82B CD21 y+ GAL80 
Figure 4.19 C, C’: yw, tub.GAL4, hs.flp, UAS nucGFP-myc ; ex.lacZ/+ ; FRT82B wtsx1/ 
FRT82B CD21 y+ GAL80   
Figure 4.19 D, D’: yw, tub.GAL4, hs.flp, UAS nucGFP-myc ; ex.lacZ/+ ;  
FRT82B mask10.22, wtsx1/FRT82B CD21 y+ GAL80 
Figure 4.20: yw, hs.flp/+ ;; FRT82B wts X1/FRT82B GFP 
Appendix:  
Figure A.1 A: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; UAS.YkiV5, FRT82B/  
FRT82B CD21 y+ GAL80  
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Figure A.1 B: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; UAS.Yki S168AV5, FRT82B/  
FRT82B CD21 y+ GAL80  
Figure A.1 C: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; UAS.Yki S111A-S168A-S250AV5, 
FRT82B/ FRT82B CD21 y+ GAL80  
Figure A.1 D: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; UAS.YkiV5,  
FRT82B mask10.22/FRT82B CD21 y+ GAL80  
Figure A.1 E: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; UAS.Yki S168AV5, FRT82B 
mask10.22/FRT82B CD21 y+ GAL80  
Figure A.1 F: yw, tub.GAL4, hs.flp, UAS nucGFP-myc/+ ;; UAS.Yki S111A-S168A-S250AV5,  
FRT82B mask10.22/FRT82B CD21 y+ GAL80  
2.2 Histology 
2.2.1  Wing mounting 
Flies were placed in 100% ethanol over night (flies can be stored in ethanol and 
dissected later). Wings were dissected away from the body in 70% ethanol, then rinsed 
in distilled water, and mounted on a slide in a drop of Hoyer’s solution.  
Samples were imaged on an "axioplan 2 imaging" Zeiss upright microscope and images 
processed using Adobe Photoshop software.  
Hoyer’s solution:  
Gum arabic (acacia)  30g 
Glycerol   16ml 
Chloral hydrate  200g 
Distilled water  50ml 
2.2.2  Photographs of adult eyes 
Flies were positioned appropriately in a petri dish with a latex bottom filled with 
ethanol, and pined down with an insect needle. Samples were imaged on a Leica MZ16 F 
Stereomicroscope and images processed using Adobe Photoshop software. 
2.2.3  Scanning Electron Microscopy (SEM) of adult eyes  
Processing and imaging of the samples was carried out by Hannah Armer from the 
Cancer Research UK Electron Microscopy Unit.  
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Samples were fixed in 2.5% gluteraldehyde plus 4% paraformaldehyde in phosphate 
buffer for one hour.  Samples were post-fixed in osmium tetroxide and dehydrated 
step-wise to 100% ethanol.  Samples were transferred to 100% acetone and critical 
point dried. 
For SEM: Samples were mounted on SEM stubs, sputter coated with platinum and 
viewed in a JEOL FESEM 6700. 
2.2.4  Drosophila adult eye sections 
Fixation and embedding for microscopy: The head was dissected away from the 
body, and one of the eyes was gently cut away with a razor blade to expose the inside 
of the head and other eye. Putting pressure on the head was avoided when cutting as 
it may deform the eye. The dissected head was placed into 2% glutaraldehyde in 0.1M 
phosphate buffer (pH 7.2) in an eppendorf tube and placed on ice for 15-30 min. The 
head was then processed according to the following protocol (under a hood with 
gloves):  
1. Add an equal volume of 2% osmium tetraoxide (OsO4: volatile and extremely toxic) 
in phosphate buffer. Incubate on ice for 30 min.  
2. Remove the glutaraldehyde/OsO4 mixture and wash the tube by filling the tube 
completely with phosphate buffer. Dispose of the waste glutaraldehyde and OsO4 in 
a bottle containing corn oil in excess. The deactivated solution can then be safely 
removed. Add fresh 2% OsO4 in phosphate buffer to the tissue and incubate on ice 
for 1-2 hours.  
3. Discard the OsO4 and dehydrate the tissue by successive 10 min incubations in the 
following ethanol solutions: 30%, 50%, 70%, 90%, 100%. Repeat the final 100% 
EtOH incubation. 
4. Replace the final ethanol treatment with propylene oxide and incubate for 10 min 
(use hood and gloves). Repeat the propylene oxide wash twice. In the mean time, 
soft durcupan resin (Fluka) is placed in a heat block at 50 °C to melt.  
5. Add an equal volume of durcupan to the last propylene wash and thoroughly mix. 
Handle resin with non-latex gloves as it is carcinogenic when unpolymerised. 
Incubate for 2 hours. 
6. Replace the resin/propylene oxide mixture with pure resin and incubate over night 
at room temperature.  
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7. Using a needle, transfer a fixed head to a mould filled with melted resin (silicon 
rubber flat embedding mould). Orient the head so that the eye is close to the edge 
and facing the cutting surface, anterior facing up. Make sure that the head is flat 
and resting at the bottom of the mould. Bake the resin at 70 °C overnight. Bake 
any resin before discarding. 
                                                      
Sectioning and staining specimen 
The resin block was trimmed around the eye with a razor blade so that the tip of the 
resin block formed a pyramid with the eye on top. Excess resin covering the eye 
surface was trimmed away.  
2.5 μM thick sections were cut using a microtome (DIATOME) and transferred in a drop 
of distilled water on a slide. The slide was then placed on a heating block at 80 °C until 
the water had evaporated and stained with a drop of toluidine blue for 30 seconds, 
then rinsed with distilled water, dried, and mounted under a coverslip with a drop of 
Neutral mounting medium.   
2.2.5  Human oesophageal epithelia staining 
Adult human tissue processing, embedding and antibody stainings were performed by 
the Cancer Research UK Experimental HistoPathology laboratory.  The tissues were 
processed, embedded and sectioned at 4 μm.  Sections were de-waxed in xylene, 
dehydrated by passage through graded alcohols to water. If required for antigen 
retrieval, sections were microwaved in citrate buffer pH6 for 15 minutes and then 
transferred to PBS. Endogenous peroxidase was blocked using 1.6% hydrogen peroxide 
in PBS for 10 minutes followed by washing in distilled water. Normal serum diluted to 
10% in 1% BSA was used to block non-specific staining in the tissue for 30 minutes. 
Slides were incubated with Primary antibody (X) diluted to X in 1% BSA for 1 hour at 
room temperature. Sections were washed in PBS prior to applying secondary antibody – 
biotinylated X anti X 1:X for 45 min at room temperature. Sections were then washed 
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in PBS and then incubated in ABC (Vector Laboratories PK-6100) for 30 minutes. 
 Following washing in PBS, DAB solution was applied for 2-5 minutes with development 
of the colour reaction being monitored microscopically. Slides were washed in tap 
water, stained with a light haematoxylin, dehydrated, cleared and then mounted.  
2.2.6  Immunostaining of Drosophila tissues  
2.2.6.1  Imaginal discs 
Wing or eye imaginal discs were dissected in ice cold PBS and processed as follows:  
1. Fix 30 minutes in PBS + 4% formaldehyde  
2. Rinse 1x in PBT then wash and permeabilise 2x 10 min in PBT  
3. Block 45 min in BBT  
4. Incubate over night at 4 °C in BBT and primary antibody  
5. Wash 4x30min in BBT 
6. Incubate in BBT and secondary antibody for 2 hours at room temperature 
7. Wash 4x 15 min in PBT, first wash with 1 μg/ml DAPI (4’,6-diamidino-2-
phenylindole dihydrochloride, Molecular Probes) to stain DNA. 
8. Mount in Fluoromount G (Southern Biotechnology) with gum in corners of the 
coverslip to avoid squashing the discs. 
Samples were imaged on a Leica SP5 confocal and images processed using Adobe 
Photoshop software.  
Solutions:  
PBS (Phosphate buffered saline):  
NaCl 8 g/L, KCl 0.25 g/L, Na2HPO4 1.43 g/L, KH2HPO4 0.25 g/L, in distilled water.  
PBT(Phosphate buffered saline with Triton): PBS + 0.1 % TritonX-100 (the percentage 
of Triton can be modified in some particular experiments) 
BBT: PBS + 0.1 % TritonX-100 +0.1% BSA (Bovine Serum Albumine, Sigma) 
2.2.6.2  Adult gut dissection 
Adult flies were dissected in PBS on ice. The abdomen was opened and the gut was 
detached carefully, without stretching. Most of the Malpighian tubules were removed to 
prevent tangling. Guts were placed in an eppendorf and processed the following way: 
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1. 30 min fixation in 4% paraformaldehyde in 0.5X PBS  
2. Wash 4 x 5 min in 0.1% PBT 
3. 30 min permeabilisation in 0.3% PBT 
4. Pre-block 1 hour at room temperature in 10% BSA 0.1%PBT 
5. Primary antibody in 5% BSA 0.1%PBT overnight at 4°C 
6. Wash 4 x 5min in 0.1% PBT 
7. Pre-block 1 hour at room temperature in 10% BSA 0.1% PBT 
8. Secondary AB 3-4 hours at room temperature 
9. Wash 1x 5min in 0.1% PBT and DAPI to stain DNA 
10. Wash 1 x 5 min 0.1% PBT 
11. Wash 1x in PBS 
12. Mount in Fluoromount G (Southern Biotechnology) with gum in corners of coverslip 
to avoid squashing the guts.  
2.3 Drosophila cell cultures 
2.3.1  Media 
Drosophila S2 cells were grown in Drosophila Schneider medium (Invitrogen) containing 
10% FBS, 50 μg/ml penicillin, and 50 μg/ml streptomycin.  
Drosophila S2R+ cells were grown in Shields and Sang M3 insect medium (Sigma) 
containing 10% FBS, 1 % Glutamax (Invitrogen), 50 μg/ml penicillin, and 50 μg/ml 
streptomycin. 
2.3.2  Transfection 
Cells were plated in 6 well plates (1.5 mL medium/well) 
Cells were transfected using the Effectene transfection reagent with the following 
protocol (for 1 well):  
1. Mix 200 ng of each construct to be transfected in 100 μl of EC buffer, vortex 1s 
2. Add Effectene enhancer (10 μl/200ng DNA), vortex 1 s  and incubate 2 min 
3. Add Effectene reagent (5 μl/200ng DNA), vortex 5-10 s, incubate 10 min at RT 
4. Pipette 400 μl from the well to transfect and add it to the Effectene/DNA mix, 
then pipette the mix gently back in the well.  
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2.3.3  Fixation and antibody staining of cultured Drosophila S2R+ cells 
Cells were cultured in 12-well plates on a 13mm sterile coverslip at a density of 3-
5.105 cells per well. 
Cells were fixed and stained according to the following protocol: 
1. Rinse cells once with PBS 
2. Fix with 4% formaldehyde in PBS for 10 minutes 
3. Wash/permeabilise 3x 15 min in PBT (0.1% Triton in PBS) 
4. Block 15 min in PBS + 5% BSA 
5. Primary antibody incubation in PBS + 5% BSA overnight at 4°C  
6. Wash 3 x 15 min in PBT  
7. Secondary antibody incubation for 2 hours at room temperature 
8. Wash 3 x 15 min in PBT with a 5 min DAPI staining between 2 washes 
9. Seize the coverslip with forceps, gently dry the sides on a thin tissue, without 
touching the surface with the cells, and place the coverslip face down on a drop of 
Fuoromount G (Southern Biotechnology) on a slide.  
Primary antibodies were used two folds less concentrated than in fly tissue 
immunostainings. Secondary antibodies used at a 1:2000 dilution. 
2.4 Human cell cultures 
2.4.1  Medium 
Cells were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented 
with10% FBS, 1 % L-Gutamin, 50 μg/ml penicillin, and 50 μg/ml streptomycin. 
2.4.2  Cell l ines 
MCF10A is a non-transformed cell line derived from a human fibrocystic mammary 
tissue.  
HEK293 is a transformed cell line derived from human embryonic kidney cells.  
2.4.3  Immunostainings 
Cells were cultured in 12-well plates on a 13mm sterile coverslip. Cells were fixed and 
stained according to the following protocol: 
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1. Rinse cells once with PBS 
2. Fix with 4% paraformaldehyde in PBS for 10 minutes 
3. Wash/permeabilise 3x 15 min in PBT (0.1% Triton in PBS) 
4. Block 15 min in PBS + 5% BSA 
5. Primary antibody incubation in PBS + 5% BSA, overnight at 4°C  
6. Wash 3 x 15 min in PBT  
7. Secondary antibody incubation in PBS + 5% BSA for 1-2 hours at room temperature 
8. Wash 3 x 15 min in PBT with a 5 min DAPI staining between 2 washes 
9. Seize the coverslip with forceps, gently dry the sides on a thin tissue, without 
touching the surface with the cells, and place the coverslip face down on a drop of 
Fluoromount G (Southern Biotechnology) on a slide.  
2.5 Antibodies  
Drosophila immunostainings: 
Mouse anti-β-galactosidase (Promega) 1:500 
Rabbit anti-β-galactosidase (Cappel) 1:200 
Rabbit anti-Mask (Michael Simon) 1:500 (1:100 for intestine) 
Rat anti-Yki 69 (Nic Tapon) 1:500 (1:100 for intestine) 
Mouse anti-V5 1:100 (Abcam) 
Rat anti-ELAV 1:300 (DHSB) 
Human cells immunostainings: 
Goat anti-Mask1/ANKHD1 (Santa-Cruz) 1:100  
Mouse anti-Mask2/ANKRD17 (Sigma) 1:100  
Goat anti-Mask2/ANKRD17 (Santa-Cruz) 1:100  
Rabbit anti-YAP (Santa-Cruz) 1:200  
Secondary antibodies: 
Alexa-fluor secondary antibodies (Invitrogen) 1:500 
 
The following antibodies were used in western blot analysis:  
Rabbit anti-PS168-Yki (N. Tapon) 1/1000 
Rabbit anti-GFP (Torrey Pines) 1/5000 
Rabbit anti-FLAG (Sigma) 1/250 
Rabbit anti-Mask1/ANKHD1 (Sigma) 1:500 
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Rabbit anti-Mask2/ANKRD17 (Novus) 1: 2000 
Mouse anti-Tubulin DM1A (Sigma) 1:1000 
Rabbit anti-YAP (Santa-Cruz) 1:500  
Mouse anti-Tubulin DM1A (Sigma) 1:1000 
Secondary antibodies:  
Anti-rabbit Peroxidase conjugated goat antibody (Thermo scientific) 1:10,000 
Anti-mouse Peroxidase conjugated goat antibody (Thermo scientific) 1:10,000 
2.6 Molecular biology 
2.6.1  Drosophila genomic DNA preparation 
One fly was ground with a pellet pestle in an eppendorf tube containing 40 μl of 
squishing buffer (10 mM Tris-HCl ; 1 mM EDTA ; 25 mM NaCl ; 200 g/ml Proteinase K 
freshly added).  The mix was incubated at 37 °C for 30 min, then at 95 °C for 5 min to 
inactivate the proteinase K. 
2.6.2  DNA ethanol precipitation 
DNA precipitation of a DNA solution of a given volume was carried out according to the 
following protocol:  
1. Add 1/10 volume of 3M Sodium Acetate (pH5.5) to the DNA solution  
2. Add 3 volumes of ethanol (100%) 
3. Mix briefly and incubate on dry ice for 5 min 
4. Spin at 13 000 rpm for 10 min on a bench centrifuge (15.7 rcf) 
5. Discard supernatant (carefully so that DNA pellet is undisturbed) 
6. Wash pellet with 70% ethanol 
7. Spin 5 min at 13 000 rpm 
8. Carefully discard the supernatant without touching the pellet 
9. Spin 2 min at 13 000 
10. Remove as much as possible of the remaining ethanol using a fine tip and leave the 
tube open for 5-10 min to allow the pellet to dry 
11. Resuspend the pellet in distilled water or buffer 
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2.6.3  Cloning of second Inverted Repeats for candidate gene validation 
For each candidate gene, PCR primers were designed to amplify a 300 base pair region 
with no predicted off targets using E-RNAi application (Horn and Boutros, 2010). For a 
given candidate gene, 3 primers were used to carry out 2 PCRs on Drosophila genomic 
DNA:     
1- forward primer (F): with a BglII restriction site added at the 5’ end.  
2- reverse primers: both primers have the same sequence but differ by the restriction 
sites added at their 5’ end: XbaI (RX) and EcoRI (RE).  
CG12818 second hairpin primers: 
F: 5’ GAGAGAAGATCTCCTTCAATACCCCACAAGGA 3’ 
RX: 5’ GAGAGATCTAGACTAGAGCATATTTTGCTTTGCTAAC  3’ 
RE: 5’ GAGAGAGAATTCCTAGAGCATATTTTGCTTTGCTAAC 3’ 
CG32133 second hairpin primers: 
F: 5’ GAGAGAAGATCTAAATGGCGTCCAGCACTC 3’ 
RX: 5’ GAGAGATCTAGATTTCGTCCACCACGATTTTT 3’ 
RE: 5’ GAGAGAGAATTCTTTCGTCCACCACGATTTTT 3’ 
 
Two PCR reactions were set up with the Invitrogen Taq polymerase using (i) the BglII 
forward primer and EcoRI reverse primer, and (ii) BglII forward primer and XbaI reverse 
primer. PCR products were purified, digested and ligated in a pMF3 vector. Because of 
the restriction sites design, the 2 PCR products are ligated in the vector as an inverted 
repeat (Fig 2.4).  
Reaction:                         Final concentration 
Genomic DNA (100 ng)   
10x buffer (no Mg++)              1X 
50mM MgCl2                        1.5 mM 
10mM dNTPs (2.5mM each)    0.2 mM each  
primers (10 μM each)             0.5 μM each 
Taq DNA Polymerase (5u/ml)  0.025 U/μl 
Distilled water     
         
PCR Programme (Bio-Rad DNA Engine): 
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94oC x 3 min 
94oC x 30s, 55oC x 30s, 72oC x 1min – 40x cycles 
72oC x 10 min 
PCRs were checked on a 1% agarose gel and purified using the Qiaquick PCR 
purification kit. DNA concentrations were measured with a nanodrop.  
Digests 
1 μg of each PCR product was digested with BglII + EcoRI, or BglII + XbaI restrictions 
enzymes from NEB, according to manufacturer’s instructions.  
Vector Preparation 
1 μg of pMF3 vector (pDG264) was digested with  EcoRI and Xba I restriction enzyme, 
then treated with phosphatase (Roche CIP) and gel purified on a 1% agarose gel with 
the Qiaquick Gel Purification Kit (28704). The DNA was then concentrated by ethanol 
precipitation. 
 
Ligation reaction 
A ligation reaction was set up to clone the 2 digested PCR inserts into the digested 
vector: 
10 ng Vector prep.    
10 ng BglII-EcoRI insert    
10 ng BglII-XbaI insert  
T4 DNA ligase buffer(final concentration 1X)  
0.4 U T4 DNA ligase (NEB, 400 U/ml)  
Distilled Water       
Incubate 16oC x 2h or overnight 
5 μl from the ligation reaction were transformed into SURE cells (Stratagene 200238), 
following the manufacturer’s instructions. Mini and Maxi DNA preps were carried out 
using QIAGEN kits. Presence of the constructs was tested by diagnostic digests and 
PCRs. Maxi-preps were sent to the BESTGENE company for microinjections and 
generation of transgenic Drosophila lines. 
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Figure 2.4: Second hairpin cloning schematics 
2.6.4  Drosophila cDNA synthesis 
RNA extraction was carried out using the QIAGEN RNeasy Protect Mini Kit: 30 flies were 
placed in an eppendorf tube on ice. 600 μl of Buffer RLT was added to the flies and 
they were finely grinded using a pellet pestle. The lysate was then centrifuged at full 
speed for 3 minutes and the supernatant was processed according to the kit’s 
instructions. Residues of DNA were eliminated by DNAse treatment using the Promega 
RQ1 DNAse kit. cDNA synthesis was carried out using Stratagene First strand cDNA 
synthesis kit and oligo (dT) primers. 
2.6.5  Cloning of Mask conserved domains 
mask conserved domains were first amplified from a Drosophila cDNA pool using 
QIAGEN DNA polymerase (Finnzymes) and PCR products were cloned into a blunt TOPO 
vector (Invitrogen). The following pairs of primers were used for PCR amplification from 
cDNA:  
ANKRI: 5’ CCGAGGTGAGTTCCTTTCTCC 3’ and 5’ TTGACGCATCTGATTTGGACC 3’; 
ANKRII: 5’ ACCAAACTCCATCTACAGCCTC 3’ and 5’ GTGCTGCTGTTTATGTTGCTCG 3’ ; 
ANKRII+KH,  
5’ ACCAAACTCCATCTACAGCCTC 3’ and 5’ CTTGATTAGTGCCAAAATGAGCATA 3’ 
DNA extractions were carried out using the QIAprep spin Miniprep Kit (QIAGEN). The 
cloned products were sequenced and one correct clone per construct was used for 
subsequent cloning with the Gateway system (Invitrogen). 
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Sequencing primers used to check ANKRI: 
M13F: 5' GTTTTCCCAGTCACGACGTTGTA 3' 
CS153R1: 5’ CAAATGACCGGCGGATGCAG 3’ 
CS153F3: 5’ GACATCGTCAAACTGCTGCTC 3’ 
CS165F: 5’ CGGTCATCAGTCTGTGGTGG 3’ 
ANKRII: 
CS160F: 5’ CGATACGAGGTGGTGGAACT 3’ 
CS155R: 5’ GATTACTGGTTGAGTTGGTTCCAC 3’ 
CS154EF: 5’ GGTGTTGATATCGGTGGAACCAA 3’ 
CS157R2: 5’ GT GCT GCT GTT TAT GTT GCT CG 3’ 
ANKRII+KH: M13F, CS160F, CS155R, CS154EF, CS157R2 
The 3 sequenced constructs were used as a template for PCR using Phusion high 
fidelity DNA polymerase, according to the manufacter’s instructions, with the following 
Gateway attB pairs of primers:  
ANKRI:  
5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTATGCCCGAGGTG-3’ 
 5’-GGGGACCACTTTGTACAAGAAAGCTGGGTGTTGACGCATCTGATTTGGACC-3’   
ANKRII:  
5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTATGACCAAACTCCATCTACAGCCTC-3’  
5’-GGGGACCACTTTGTACAAGAAAGCTGGGTGGGTGCTGCTGTTTATGTTGCTCG-3’  
ANKRII+KH:  
5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTATGACCAAACTCCATCTACAGCCTC-3’  
5’-GGGGACCACTTTGTACAAGAAAGCTGGGTGCTTGATTAGTGCCAAAATGAGCATA-3’  
attB PCRs products were cloned by BP recombination into a Gateway entry vector (p-
ENTR) and the sequenced ORFs were transferred by LR recombination from the entry 
vector into the gateway expression vector pAWF (ampicillin resistant) for expression of 
the peptides fused to a triple FLAG affinity tag at the C terminus, following the 
manufacturer’s instructions.   
2.6.6  Co-immunoprecipitation (Co-IP) assay 
S2 cells were plated in 6 well plates at a density of 2.106 cells/well (1,5 mL 
medium/well) and transfected with 200 ng of each construct, and harvested 48h later.  
Materials used for the Co-IP include:  
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Flag M2 resin (Sigma, A2220) 
Lysis buffer:              Final concentration 
1M Tris pH7.5               50 mM 
5M NaCl     150 mM 
Triton-X100 (or 25 ml 10% Triton-X) 1 % 
0.5M EGTA               1 mM 
 
Complete tablet, Mini, EDTA-free, Roche (use 1 tablet for 10 mL buffer) 
PhosSTOP phosphatase Inhibitor Cocktail, Roche (use 1 tablet for 10 mL buffer) 
PMSF (100 mM in isopropanol, stored at -20°C): use 10 μl/ml 
 
IP buffer preparation: Before starting the procedure, IP buffer was prepared as 
follows and kept on ice: 
For 10 mL of Lysis buffer were added 1 tablet of Complete proteases inhibitor, 1 tablet 
of PhosSTOP phosphatase inhibitor, and 100 μl of PMSF.   
 
Protein extraction: 48 h after transfection, S2 cells were detached from the well by 
pipetting up and down. The cell suspension was transfered into an eppendorf tube and 
spinned down at 3000 rpm for 2 mins at 4°C in a cold centrifuge (Heraeus Biofuge 
fresco).  
Samples were then processed according to the following steps:  
- Wash 1x in ice cold PBS, spin down again at 3000 rpm for 2 mins at 4°C.  
- Add 500 μl of ice cold lysis buffer to the cell pellet, incubate 10 mins on ice. 
- Spin down at 13000 rpm for 10 mins at 4°C to remove cell debris.  
- Transfer supernatant to a new eppendorf. Keep 50 μl as an input control and use 
the rest (roughly 450 μl) for the immunoprecipitation. 
For the rest of the procedure, tubes were maintained on ice and subsequent 
incubations and washes were carried out in a cold room (4°C). 
Protein beads preparation: M2 anti-Flag coupled beads are stored in a glycerol 
solution and must be washed 4 or 5 times in IP buffer prior to IP. In between washes, 
beads are centrifuged for 1 min at 2000 rpm in a cold centrifuge.  
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Immunoprecipitation: 
1. Add 40 μl of beads to each sample 
2. Incubate at 4°C for 2 hours on a rotating wheel. 
3. Wash 3-4x (5 mins on rotating wheel) in 500 μl freshly prepared IP buffer 
containing the protease and phosphatase inhibitors. For washing steps, spin down 
at 1000 rpm for 1 min using bench centrifuge (0.1 rcf). 
4. After last wash, remove most of the IP buffer, leaving about 15 μl. 
5. Add 4 μl reducing agent (10x, NuPAGE) and 15 μl LDS sample buffer (4x, NuPAGE) 
to each sample and proceed to Western blot analysis (Alternatively, add only the 
sample buffer and store the samples at -20°C, add the reducing agent later, prior 
to Western blot analysis).  
2.6.7  Larvae preparation for western blot analysis 
Larvae (between 10 and 30) were placed in an eppendorf containing 90 μl of LDS 
sample buffer (NuPAGE) and 10 μl reducing agent, and were finely ground with a pellet 
pestle. Samples were heated at 70°C for 10 min to denature the proteins and 
centrifuged for 5 min at maximum speed using a bench centrifuge (15.7 rcf). The 
supernatant was then used for Western blot analysis.  
2.6.8  Western blot analysis 
Using Invitrogen NuPage electrophoresis system 
Reagents (denaturing electrophoresis)      
NuPAGE LDS Sample Buffer (4X)   
NuPAGE REDUCING AGENT (10X)    
Buffers:  
TBS (Tris-buffered saline): NaCl 8g, KCl 0.2g, Tris base 3g, in 800ml distilled water, adjust pH to 
8.0 with 1M HCl, adjust volume to 1000ml, sterilise by autoclaving.  
TBST (Tris-buffered saline with Tween): TBS + 0.1% Tween 
 
LDS sample buffer and reducing agent were added to the sample and the mix was 
heated for 10 minutes at 70 °C in a heat block. Samples were then resolved on 10% 
Bis-Tris polyacrylamide or 3-8% Tris-Acetate or 4-12% Bis-Tris precast polyacrylamide 
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gradient gels (NuPAGE). Protein sizes were marked using the Rainbow molecular weight 
marker (Amersham).  
Proteins were subsequently transferred to a nitrocellulose membrane using the iBlot 
system (Invitrogen). After transfer, membranes were processed according to the 
following protocol (incubations on a rotating table):  
1. Block for 1 hour in block solution (TBST+5% dried milk powder) 
2. Incubation in primary antibody at the appropriate dilution in block solution for 2 hrs 
at room temperature or overnight at 4°C followed by 3 brief rinses and 3x 5 min 
washes in TBST. 
3. Secondary antibody incubation (1/10 000 dilution) in block solution for 1 hr at 
room temperature followed by 3 brief rinses and 3x 5 min washes in TBST. 
4. Incubation with Super Signal West Pico Chemiluminescent Substrate (Pierce), 
according to the manufacturer’s instructions. 
Reblot  
Blots were stripped and rebloted using the Millipore re-blot kit.  
2.6.9  Luciferase assay in human cells 
siRNAs 
3 different pools of siRNAs were used at a final concentration of 300 nM (75nM of 
each individual siRNA):  
ON-TARGETplus Set of 4 Mask1/ANKHD1 (Dharmacon) 
ON-TARGETplus Set of 4 Mask2/ANKRD17(Dharmacon) 
ON-TARGETplus Non targeting pool (Dharmacon) 
 
The luciferase assay was performed in sextuplicates in a 96 well plate. 48 hours after 
transfection, cells were lysed and tested for Luciferase and Renilla activity using the 
Dual-luciferase reporter assay system kit (Promega) and a luminometer.  
 
The night before transfection, HEK293T cells were plated in a white 96 well plate (BD 
falcon 353288) at a density of 15.000 cells/well, and a volume of 100 μl/well. 
Antibiotic-free growth medium was used to avoid cell lethality because of toxicity 
enhancement between antibiotics and Lipofectamine.  
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Cells were transfected using the Lipofectamine 2000 reagent (Invitrogen) with siRNAs 
and 20 ng of each DNA plasmid (pCMV-Flat YAP2 5SA, pCMX-GAL4 TEAD4 and 
UAS.Luciferase) per well (with the exception of the pRL-TK Renilla vector: 3ng per well) 
with the following protocol: 
1. Set up a DNA/siRNA mix and a Lipofectamine mix:  
- DNA/RNA mix: plasmids and siRNA were mixed with optiMEM medium (Invitrogen) in a 
final volume of 30 μl/well 
- Lipofectamine mix: 0,2 μl Lipofectamine + 30 μl OptiMEM/well 
vortex 5s, incubate 5min (max=25 min) 
2. Add the Lipofectamine/OptiMEM mix to the DNA/RNA-Mix, vortex and incubate 20 
min at RT. 
3. Remove medium from the cell culture plate down to 30 μl growth medium per well  
4. Apply the 60 μl LF/DNA complexes to the wells. (Volume=90 μl /well) 
5. Incubate cells at 37°C for 48 hrs 
Cell Lysis  
Remove medium and apply 25 μl of Passive Lysis Buffer (Promega); incubate at RT for 
15 to 20 min on a rocking platform (250 rpm). (Cells can be frozen after that step and 
luciferase assay performed later) 
Luciferase assay (using the Promega dual Luciferase kit) 
1. Add Fluc Buffer, 28 μl/well, incubate 2-3 min, read the plate  
2. Add Rluc buffer, 28 μl/well, incubate 2-3 min, read the plate 
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Chapter 3.  An in vivo RNAi screen for novel growth 
regulators 
 
The control of tissue growth during development is essential to generate organs of the 
correct size and shape. Although genetic pathways involved in this process have been 
uncovered, how organs reach their final size and their correct proportions is still poorly 
understood. With the development of RNA interference (RNAi) as a tool to 
systematically knock-down genes from sequenced genomes, reverse genetics have 
proven to be a very efficient strategy to identify novel genes involved in cellular 
processes (Mohr et al., 2010). Until recently, genomic RNAi screens in Drosophila were 
limited to cell culture, and had not been used to study developmental processes. The 
creation of a Drosophila transgenic RNAi library (Dietzl et al., 2007) has extended the 
use of this technique, allowing tissue specific knock-down of any known or predicted 
Drosophila gene. Making use of this newly available tool, an in vivo RNAi screen was 
carried out in the laboratory in order to find new players in the regulation of organ size. 
My PhD project was to validate candidates from the screen and to focus on one for 
characterisation.   
3.1 The screen  
3.1.1  Principle 
The screen was carried out using a collection of transgenic Drosophila lines from the 
VDRC library (Dietzl et al., 2007). Each transgenic line contains a fragment of 300 base 
pairs from a given gene X cloned as an inverted repeat. This inverted repeat X-IR is 
under the control of the UAS promoter, which can be activated by the yeast GAL4 
transcription factor. Expression of X-IR leads to the production of RNA hairpins that are 
recognised and degraded by the cell RNA interference machinery (Fig 3.1). The small 
interfering RNAs (siRNAs) produced target the RNA Induced Silencing Complex (RISC) 
to complementary X mRNA, thereby triggering X mRNA degradation (Fig 3.1).  In total, 
11,512 UAS.IR lines, targeting a subset of Drosophila genes conserved in human, were 
crossed individually to a hedgehog.GAL4 line, so that progeny expressed the transgene 
throughout development in the posterior compartment of the wing (Fig 3.1). To avoid 
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losing progeny due to increased apoptosis, an inhibitor of apoptosis (DIAP1) was co-
expressed with the transgenes. Progeny was then screened for differences in wing size 
compared to a control. This work was carried out by B. J. Thompson. As the UAS.IR 
transgene is specifically expressed in the posterior compartment, it does not affect the 
anterior compartment of the wing, which can therefore be used as an internal control 
for size.  
             
Figure 3.1: Principle of the screen 
GAL4 expression (in blue) is driven by the hedgehog promoter in the posterior compartment of 
the wing. GAL4-induced-expression of an inverted repeat from gene X triggers degradation of X 
mRNA by RNA interference.  
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3.1.2  Results 
Phenotypes were classified in different categories according to their effects on tissue 
size and cell size. In addition, the Drosophila wing is an excellent model to detect 
morphology and patterning defects such as wing hair mis-orientation, shape defects, 
vein defects, or wing margin defects, allowing the association of candidate genes with 
signaling pathways known to cause these phenotypes (Pearson et al, in preparation). I 
am not going to detail these classes of phenotypes, as my project focus was on the 
growth phenotypes categories. Of the 11512 lines screened, 8108 lines (70.4%) 
produced no observable phenotype and 1406 (12.2%) lines produced viable flies with 
phenotypes. Despite the co-expression of DIAP1, 17.4% of UAS.IR transgenes caused 
lethality prior to eclosion (1998 lines). The screen efficiency was estimated by looking 
at the recovery rate of genes from the Insulin signaling pathway: approximately half of 
the known pathway components were recovered in the screen. Thus, by extrapolation, 
approximately half the UAS.IR transgenes from the VDRC library trigger a sufficient 
gene silencing to generate a phenotype.  
Undergrowth phenotypes 
RNAi knock down of genes promoting cell cycle progression, such as cdc25/string, lead 
to an undergrowth phenotype accompanied by an increase in cell size, apparent by the 
reduced density of wing hairs, as each wing cell produces a single hair (Fig 3.2 A). This 
increase in cell size is due to the fact that the cell cycle is slowed down but the rate of 
cell growth is not affected [(Neufeld et al., 1998), Chapter 1]. Therefore, cells grow at 
the same rate but for longer periods between divisions. In this category, a number of 
known cell cycle regulator were recovered as well as some novel genes.  
By contrast, downregulation of cell growth promoting genes, such as the Insulin 
pathway component akt, leads to an undergrowth phenotype accompanied by a 
reduction in cell size, apparent by an increase in wing hair density (Fig 3.2 A). In this 
category were recovered members of the Insulin/TOR pathway, ribosomal proteins, 
general transcription and translation factors, other essential genes such as 
mitochondrial genes, and a number of novel genes.   
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Genes promoting cell proliferation control both cell growth and cell cycle progression. 
Hence, downregulation of genes promoting cell proliferation lead to tissue undergrowth 
without strong effects on cell size (Fig 3.2 B). In this category were recovered ajuba 
and zyxin, from the Hippo signaling pathway, as well as components of the Ras 
signaling pathway, such as raf and sos, that presented vein loss in addition to their 
undergrowth phenotype, consistent with the role of Ras signaling in regulating both cell 
proliferation and vein patterning in the wing.  Yki was not recovered in this category, as 
expression of yki-IR in the wing was lethal. In addition, a number of novel genes were 
identified.   
Overgrowth phenotypes 
Several genes producing overgrowth phenotypes were uncovered in the screen. Among 
those are known members of growth control signaling pathways such as the Hippo 
pathway, the Ras pathway, the Insulin/TOR pathway, as well as some apico-basal 
polarity proteins such as Crumbs and a number of novel genes (Fig 3.2 C). Apart from 
genes from the Insulin/TOR pathway, most lines in this category did not significantly 
alter hair density.  
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Figure 3.2: Growth phenotypes from the screen 
Transgenic RNAi lines are expressed in the posterior compartment of the wing with the hh.GAL4 
driver. (A) Undergrowth phenotypes strongly affecting cell size: knock-down of the Insulin 
pathway component akt results in an undergrowth phenotype accompanied by a reduction in cell 
size that can be observed from the higher density of wing hairs. Knock-down of the cell cycle 
regulator cdc25 results in an undergrowth phenotype accompanied by an increase in cell size 
that can be observed from the lower density of wing hairs. (B) undergrowth phenotypes of genes 
affecting cell proliferation. (C) Overgrowth phenotypes. 
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3.2 A systematic approach to validate the candidate genes 
identified in the screen  
3.2.1  Strategy of validation 
One possible source of false-positive artefacts in the screen is the off-targeting effect 
of siRNAs. Indeed, although transgenes were specifically designed to avoid non-specific 
gene targeting, some siRNAs may present complementarities with more mRNAs than 
the one they were designed to target. In order to rule out this artefact, we validated 
screen hits by testing second UAS.IR lines, targeting a different sequence of the 
candidate gene than the one targeted by the first hairpin. When they were available, we 
used RNAi lines from the NIG-FLY library, an independent library of transgenic RNAi lines 
(http://www.shigen.nig.ac.jp/fly/nigfly/; Table 1). We also generated second UAS.IR 
lines for some of the interesting candidates when they were not available from NIG-FLY.  
3.2.2  Results 
We started by testing candidates from the overgrowth phenotype category. A total of 
12 novel genes were tested. 6 genes had multiple UAS.IR transgenic lines available 
from NIG-FLY (Table 1). For the 6 remaining genes, we cloned inverted-repeat 
constructs and generated transgenic UAS.IR lines. 2nd hairpins for CG6422, CG30046, 
CG9286 and CG33967 were cloned by Ruth Brain, while 2nd hairpins for CG32133 and 
CG12818 were cloned by myself. Transgenic lines were individually crossed to the 
hh.GAL4 driver line and the progeny was screened for overgrowth phenotypes. Among 
the 12 overgrowth phenotype candidates tested, only 1 was confirmed by the second 
hairpin: CG33967 or Kibra, which was subsequently characterised by A. Genevet in a 
collaboration with the Tapon laboratory (Genevet et al., 2010). This rate of validation 
appears much lower than expected and remained unexplained until Ruth Brain 
investigated the genomic location of UAS.IR transgene insertions by inverse PCR and 
found that more than 50% of overgrowth phenotype were associated with insertions of 
the UAS.IR transgenes near the miR278 locus, a micro RNA known to cause 
overproliferation when mis-expressed (Nairz et al., 2006), indicating that the UAS 
promoter is able to activate miR278 when it is inserted nearby. CG6422, CG30046 and 
CG9286 phenotypes were due to this mis-expression artefact.  
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In the undergrowth category, candidates were selected according to their conserved 
domains and predicted functions, to avoid selecting housekeeping genes whose 
downregulation causes growth defects due to lower cell survival rather than specific 
mis-regulation of tissue growth. 32 of the selected genes had multiple available UAS.IR 
lines in the NIG-FLY library and were therefore tested with the hh.GAL4 driver (Table1 ; 
a detailed list with the individual transgenic lines ID and phenotypes can be found in 
Appendix, Table 2).  The rate of confirmation was much higher than in the overgrowth 
category. Undergrowth phenotypes of 17 out of the 32 selected genes were confirmed 
by expression of the second UAS.IR line (Table 1; Fig 3.3). 2 of them were lethal, so 
their growth phenotype could not be investigated. One of the candidate genes 
confirmed by a strong undergrowth phenotype with the second hairpin is the mask 
gene, which characterisation will be described in the next chapters. We chose this gene 
for its very strong and specific effect on tissue size without effects on patterning, a 
phenotype similar to that of Hippo signaling components such as zyxin and ajuba.  
3.2.3  Conclusions 
Following the finding that, in addition to the off-target effect, false-positives could be 
generated by mis-expression of genes neighbouring the UAS.IR transgene, validation of 
hits by a second independent UAS.IR line appears crucial. This strategy of validation has 
allowed confirmation of phenotypes for about half of the candidates tested. One of 
them, the mask gene, presented a particularly striking tissue size reduction without 
effects on tissue patterning, a phenotype similar to that of Hippo signaling negative 
regulators recovered in the screen. I chose to focus on that gene for further 
characterisation.  
In 2009, a second generation library (KK library) was constructed by the VDRC using 
an engineered transgene landing site inserted on chromosome 2, carefully chosen to 
guarantee an optimal level of UAS.IR transgene expression upon GAL4 induction. Thus, 
all transgenes from the new library are inserted in the same unique genomic site and 
are expressed at the same level, thereby limiting the number of false-positive hits, by 
preventing mis-expression artefacts, and false-negatives, by ensuring optimised levels 
of UAS.IR transgene expression. In order to consolidate results from the first screen, 
the screen was repeated with all available KK library transgenic lines targeting 
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conserved genes (5802 lines). This second screen has allowed the identification of 
novel growth regulators with a high degree of confidence (Pearson et al, manuscript in 
preparation).    
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Table 1: List of candidate genes tested for validation with 2nd hairpin l ines from 
the NIG-fly l ibrary 
Validated candidates are highlighted in yellow, lethal phenotypes are highlighted in grey.  
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Figure 3.3: Validated candidate genes from the screen 
2nd hairpins are expressed in the posterior compartment under the control of the hh.GAL4 driver.
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Chapter 4.  Identification of Drosophila Mask as an 
essential co-factor of Yki in the Hippo signaling 
pathway 
 
4.1 Identification of Mask as an essential regulator of growth 
4.1.1  Mask : Multiple Ankyrin and Single KH domain protein 
One of the candidate genes uncovered in the screen is the mask gene (CG6313). 
Expression of mask-IR in the whole wing (with the MS1096.GAL4 driver) or in the eye 
(with the ey.GAL4, GMR.GAL4 driver) causes a strong undergrowth phenotype 
compared to control (Fig 4.1). mask is an essential gene encoding a large protein of 
4001 amino acids, which is composed of two blocks of ankyrin repeats and a single KH 
domain (Fig 4.2). Ankyrin repeats are motifs of 33 amino acids repeated from 2 to 24 
times. In the case of Mask, the first block of ankyrin repeats contains 15 repeats, and 
the second block contains 10 repeats. These motifs are known to mediate protein-
protein interactions but do not bind to a consensus protein sequence. They are present 
in a large number of proteins, involved in a variety of processes, including cyclin 
dependent kinase inhibitors, transcriptional regulators, cytoskeletal organizers and 
developmental regulators (Michaely and Bennett, 1992). The KH domain is a nucleic 
acid binding domain that can bind to RNA or single stranded DNA and is found in 
various proteins including RNA splicing factors, translational and transcriptional 
regulators (reviewed by (Valverde et al., 2008)). Mask sequence also contains 2 
putative coiled-coil regions, a predicted nuclear export signal (NES) and a predicted 
nuclear localisation signal (NLS). Mask protein is well conserved among metazoans and 
it has 2 homologues in human that I will describe in Chapter 5: ANKHD1, which I will 
refer to as Mask1, and ANKRD17, which I will refer to as Mask2. Despite a low 
conservation in some regions of the protein, the ankyrin repeat blocks and the KH 
domain, as well as the predicted NES and NLS, are highly conserved (Fig 4.2). 
Drosophila mask was originally identified in a modifier screen for new components of 
receptor tyrosine kinase signaling. It was found to genetically interact with the protein 
tyrosine phosphatase Corkscrew (Csw) (Smith et al., 2002). Csw participates in 
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signaling by the Receptor tyrosine kinases (RTKs) Torso, Sevenless (Sev) and 
Drosophila Epidermal growth factor Receptor (EGFR) (Allard et al., 1996; Herbst et al., 
1996; Perkins et al., 1992) (Perkins et al., 1996). RTKs transduce signals through a 
common set of signaling molecules that lead to the activation of the Ras/MAPK 
pathway. Although its exact role is not clear, Csw binds to RTKs through scaffolding 
proteins and is required for RTK signaling and MAPK activation. In the wing, mutation of 
csw causes undergrowth and partial vein loss (Perkins et al., 1996). Furthermore, 
expression of a dominant negative form of Csw in the eye causes strong undergrowth 
and loss of photoreceptors R3, R4 and R7 (Allard et al., 1996).  These effects on 
growth and patterning are characteristic phenotypes of genes affecting Receptor 
Tyrosine kinase signaling: patterning of the wing veins is also dependent on EGFR 
signaling (Martín-Blanco et al., 1999) and photoreceptor specification relies on EGFR 
and Sev signaling (Doroquez and Rebay, 2006; Freeman, 1996; Hafen et al., 1987). 
Smith et al. found that in the eye, mutation of one copy of mask enhances the 
undergrowth and loss of photoreceptor phenotype induced by the expression of a 
dominant negative form of Corkscrew (cswCS). Mask mutants are also able to suppress 
the ectopic R7 photoreceptor phenotype induced by hyper-activation of Sev, Csw, or 
Ras. However, loss of mask does not affect MAPK activation, indicating that Mask acts 
either downstream of MAPK signaling, or in parallel. 
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Figure 4.1: mask RNAi causes tissue undergrowth in the wing and in the eye.   
(A) Wild-type adult Drosphila wing. 
(B) RNAi knockdown of the mask gene during wing development results in an abnormally small 
wing. 
(C) Wild-type adult Drosophila eye. 
(D) RNAi knockdown of the mask gene during eye development results in an abnormally small 
eye. 
 
 
 
Figure 4.2: Mask protein is conserved in humans 
Drosophila Mask, human Mask1 and human Mask2 schematic representation. 
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4.1.2  Mask is essential for tissue growth in Drosophila 
We further analysed mask phenotype by making use of the embryonic lethal mask10.22 
mutant allele generated by Smith et al., which contains a nonsense mutation and 
produces a protein truncated of 80% of its sequence (Smith et al., 2002). The ey.flp 
FRT Minute system was used to generate mask10.22 homozygous mutant eyes. mask10.22 
homozygous mutant clones of cells carrying a wild-type Minute allele, marked by the 
absence of a white+ marker, were generated in a tissue heterozygous mutant for the 
homozygous lethal Minute gene, marked by the presence of a w+ marker. Minute 
mutant cells are outcompeted by cells carrying the wild type Minute allele, resulting in 
an eye mostly composed of non-pigmented mask10.22 homozygous mutant cells. This 
was confirmed by the small number of ommatidia expressing the w+ marker (Fig 4.3 A-
B’). mask10.22 mutant eyes were much smaller than controls (Fig 4.3 A-B’), similar to 
mask-IR eyes, indicating that the RNAi line strongly down-regulates mask. We also 
generated mask10.22 mutant clones in the developing larval wing imaginal disc using the 
FLP/FRT system. This genetic tool allows the generation of a homozygous mutant 
clone of cells marked by the absence of GFP, and a twin clone of wild type cells (or 
twin-spot) expressing a double dose of GFP, in a heterozygous mutant tissue 
expressing GFP. mask10.22 mutant clones proliferated poorly, growing to only 10% of 
the size of their wild type twin-spots (Fig 4.3 C-E).  
In order to investigate the effect of Mask over-expression, we used the P-element 
P{EPgy2}EY01848. This transposon is inserted 0.8 kb before the mask start codon and 
contains a UAS sequence in the same orientation as the mask gene.  To test this 
insertion we used a Mask antibody from M. Simon (Smith et al., 2002). The specificity 
of Mask antibody was verified by immunostainings in wing discs containing mask10.22 
mutant clones. Although some mild background noise could be detected, the antibody 
staining was mostly lost in the mutant clones compared to the surrounding wild type 
tissue (Fig 4.4). When crossed to the hh.GAL4 driver, P{EPgy2}EY01848 was able to 
drive the over-expression of Mask in the wing disc, detected by an increase in Mask 
antibody staining in the posterior compartment (Fig 4.5 A,B). In some rare cases adult 
wings presented nicks in the posterior wing margin but in most cases growth of the 
wing was not affected (Fig 4.5 C,D). The lack of phenotype could be due to the fact 
that EP lines usually do not strongly activate gene expression. Expression of a mask 
Chapter 4. Drosophila mask characterisation 
 73 
transgenic construct under the control of a UAS promoter may cause a more obvious 
phenotype. To date, mask gene has not been cloned due to its large size. These data 
show that mask is essential for cell proliferation and tissue growth but its 
overexpression does not seem to be sufficient to induce tissue overgrowth. 
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Figure 4.3: mask mutant confirms mask RNAi phenotype 
(A) Control (white) adult eye.  Top view in (A’). 
(B) A mask10.22 homozygous mutant eye generated with the eyFlp Minute sytem is small and 
rough.  Top view in (B’). 
(C-E) Third instar wing imaginal discs containing mitotic recombination clones. Clones were 
induced by heat shocking larvae at 84 hr (± 12 hr) of development. 
(C) Third instar wing imaginal disc containing control (GFP negative) mitotic recombination clones 
and sister twin-spot clones (2x GFP) of similar size.  DAPI (blue) marks nuclei. 
(D) Third instar wing imaginal disc containing mask10.22 homozygous mutant clones (GFP 
negative) that are drastically smaller than their sister twin spots (2x GFP). DAPI (blue) marks 
nuclei. 
(E) Quantification of the ratio between clone and twin sizes in (C) and (D). 
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Figure 4.4: Mask antibody staining is lost in mask10.22  mutant clones 
Third instar wing imaginal disc stained with Mask antibody (red). mask10.22 mutant clones were 
generated using the MARCM system and are marked by the expression of NLS-GFP (green). DAPI 
stains nuclei (blue).   
 
 
 
Figure 4.5: Mask overexpression does not drive tissue overgrowth.  
(A) Third instar wing imaginal disc stained with anti-Mask (green) 
(B) Third instar imaginal disc expressing Mask in the posterior compartment under the control of 
P{EPgy2}EY01848 driven by hh.GAL4, stained with anti-Mask (green) 
(C) Adult control wing 
(D) Adult wing overexpressing Mask in the posterior compartment under the control of 
P{EPgy2}EY01848 driven by hh.GAL4 
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4.1.3  Mask mutant does not affect patterning  
Despite the strikingly small size of mask-IR expressing wings, the pattern of 
differentiated features, such as veins and bristles, is not affected (Fig 4.1 A,B). This 
phenotype is different from that of genes affecting Ras/MAPK kinase signaling. For 
instance, downregulation of the Ras activated kinase Raf by expression of raf-IR in the 
posterior half of the wing results in an undergrowth phenotype similar to that caused 
by expression of mask-IR. However, by contrast with mask-IR, raf-IR undergrowth 
phenotype is also accompanied by a severe loss of veins (Fig 4.6 A-C). Thus, mask 
does not regulate vein patterning in the wing.  
The wild type adult eye is composed of about 800 clusters of cells, called ommatidia, 
organised in a regular pattern across the eye. Each ommatidium contains 8 
photoreceptor cells, R1 to R8, surrounded by a fixed number of accessory 
(interommatidial) cells. R1 to R6 are arranged in a precise order around the inner 
photoreceptor cells R7 and R8 and disruptions in EGFR or Sevenless signaling result in 
loss of photoreceptor cells. In order to examine mask role in eye patterning, control 
flies carrying the eyGMR.GAL4 driver and flies expressing mask-IR with the eyGMR.GAL4 
driver were prepared for eye sectioning. In the control eye sections, each ommatidium 
presented the same organised pattern of photoreceptor cells R1 to R7 (Fig 4.6 D,D’). 
R8 cell is not visible as it is stacked under R7. Despite the strong undergrowth caused 
by down regulation of the mask gene, sectioning of mask-IR eyes revealed that the 
number of photoreceptors per ommatidium was not affected compared to wild type 
(Fig 4.6 E,E’). However, the number of interommatidial cells appeared slightly reduced 
compared to the control. This could be due to a patterning defect, or a defect in cell 
proliferation/survival. For instance, the Hippo signaling pathway is known to affect the 
number of interommatidial cells by controlling cell survival and proliferation in these 
cells. Our finding that mask mutant does not affect the number of photoreceptors is in 
contradiction with the results of Smith et al who found some loss of photoreceptors in 
mask10.22 mutant eye. This may be due to the fact that the RNAi knockdown is not as 
strong as the mutant. Loss of photoreceptors in mask10.22 mutant eyes could be due to 
a defect in cell viability, stronger in the mutant than in the RNAi knock-down. 
Consistently, our results and those of Smith et al show that mask mutant cells under-
proliferate and have a lower survival than wild type cells. In order to confirm our result, 
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we generated mutant clones of mask in the eye imaginal disc and stained with an ELAV 
antibody, a marker of neuronal differentiation used to mark differentiated 
photoreceptor cells. No loss of ELAV staining was observed in the mask mutant cells 
compared to the surrounding wild type cells (Fig 4.6 F). Thus, mask does not control 
photoreceptor cell specification. Together these data show that mask downregulation 
does not strongly affect Ras/MAPK signaling.  
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Figure 4.6: mask RNAi or mutant does not affect patterning in the wing or in the 
eye 
(A) Wild-type adult Drosophila wing.  Red dotted line indicates the posterior compartment.  
(B) RNAi knockdown of mask specifically in the posterior compartment causes undergrowth  
(C) RNAi knockdown of raf specifically in the posterior compartment causes undergrowth and 
loss of vein differentiation (arrows). Picture from BJ Thompson. (D) Section through an adult eye 
showing multiple ommatidia in which red pigment cells surround photoreceptor cells. (D’) Zoom 
from section D, single wild type ommatidium with photoreceptor cells annotated from R1 to R7. 
(E) RNAi knockdown of the mask gene causes occasional loss of pigment cells and moderate 
disorganisation of the ommatidia, but does not cause loss of photoreceptor cells. 
(E’) Zoom from section E, single ommatidium from a mask-IR expressing eye with photoreceptor 
cells annotated from R1 to R7. (F) A homozygous mask10.22 mutant clone (GFP-negative) does 
not block differentiation of ELAV-positive photoreceptor neurons in the 3rd instar eye imaginal 
disc, indicating that Ras-signalling is functional in mask mutants. 
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4.2 Mask acts in the Hippo pathway 
Mutations affecting tissue growth without affecting patterning are uncommon. Known 
examples include mutations affecting genes of the Hippo signaling pathway. For 
instance, inhibition of the Warts (Wts) kinase by expression of a wts-IR transgene in 
the wing causes tissue overgrowth without altering veins or bristles (Fig 4.7 A,B).  In 
the eye, expression of wts-IR causes tissue overgrowth and increased number of 
interommatidial cells but it does not alter the number of photoreceptors per 
ommatidium (Fig 4.7 C-E). Thus, mask-IR and wts-IR cause opposite phenotypes in the 
wing and in the eye. In addition, the mask mutant phenotype – increased apoptosis and 
reduced cell proliferation – is highly similar to that caused by mutations in the Hippo 
pathway component yki (Huang et al., 2005). Together, these data suggest that mask 
may be involved in the Hippo signaling pathway.  
 
Figure 4.7: Wts RNAi downregulation affects tissue growth but not patterning 
RNAi knockdown of the wts gene during wing development results in an abnormally large wing 
(A) compared to control (B) with no obvious defects in patterning. RNAi knockdown of the wts 
gene during eye development results in an abnormally large eye (C) compared to control (D). 
(E) RNAi knockdown of the wts gene causes a strong increase in pigment cell number, but does 
not cause a gain of photoreceptor cells. Pictures from BJ Thomspon. 
 
Chapter 4. Drosophila mask characterisation 
 80 
4.2.1   Mask is required for Yki target gene expression 
Hippo pathway signaling restricts cell proliferation by inhibiting the transcriptional co-
activator Yki. We used LacZ reporters for the Yki target genes four-jointed (fj), 
expanded (ex) and DIAP1 as a read out to test if mask was affecting Hippo signaling. 
The LacZ gene encodes the β-galactosidase bacterial protein, easily detectable by 
antibody staining. Down-regulation of mask in the posterior compartment of the wing 
by expression of mask-IR with the hh.GAL4 or the en.GAL4 driver led to a significant 
reduction in the expression of fj.LacZ, ex.LacZ and DIAP1.LacZ reporters compared to 
control (Fig 4.8).  To confirm these results, we generated mask10.22 mutant clones in 
flies carrying either of the three reporters. In mask mutant cells, the level of expression 
of Yki reporter genes was reduced compared to their level in wild type surrounding cells 
(Fig 4.9).  These results show that mask is required for the expression of Yki target 
genes.  
4.2.2  Mask binds to and colocalises with Yki 
In order to determine how Mask is involved in the Hippo pathway, we cloned tagged 
versions of Mask conserved domains to test their interaction with proteins of the Hippo 
pathway in co-immunoprecipitation assays.  We generated 3 different Flag-tagged 
constructs (Fig 4.10 A):  
- ANKRI: region containing the first block of Ankyrin repeats 
- ANKRII: region containing the second block of Ankyrin repeats  
- ANKRII+KH: region containing the second block of Ankyrin repeats and the KH domain.  
Interestingly, when expressed in cultured Drosophila S2R+ cells, ANKRI-Flag was found 
very often in the nucleus whereas Flag-ANKRII and Flag-ANKRII+KH were predominantly 
cytoplasmic (Fig 4.10 B-D). This indicates that although no consensus NLS sequence 
was found in that region, Mask may contain an NLS in ANKRI sequence. Alternatively, 
ANKRI may bind a nuclear protein. ANKRI-Flag, ANKRII-Flag and ANKRII+KH-Flag were all 
able to co-immunoprecipitate with an EGFP-tagged form of Yki (Fig 4.10 E).  The 
presence or absence of the KH domain next to the second ankyrin repeats domain did 
not affect the binding to Yki.  These results show that Mask can bind to Yki via its 
ankyrin repeat domains. We also tested the interaction of Mask conserved domains 
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with an HA tagged form of Yki partner Scalloped (Sd) but no interaction was detected 
between Mask constructs and Sd (Appendix, Fig A.1). 
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Figure 4.8: mask is required for Yki target gene expression (1) 
Third instar wing imaginal discs immunostained for Mask (green) or for β-galactosidase (red). 
Control or expressing mask-IR with the hh.GAL4 or en.GAL4 driver. 
(A) Control third instar wing imaginal disc stained with an anti-Mask antibody. 
(B) Expression pattern of the fj.lacZ reporter gene in a control wing disc. A and B are pictures 
from the same imaginal disc. (C) Expression pattern of the ex.lacZ reporter gene in a control wing 
disc. (D) Expression pattern of the DIAP1.lacZ reporter gene in a control wing disc. (E) RNAi 
knockdown of mask in the posterior compartment (dotted line) reduces the level of Mask protein 
expression. (F) RNAi knockdown of mask in the posterior compartment (dotted line) reduces the 
level of fj.lacZ expression. E and F are pictures from the same disc. (G) RNAi knockdown of mask 
in the posterior compartment (dotted line) reduces the level of ex.lacZ expression. (H) RNAi 
knockdown of mask in the posterior compartment (dotted line) reduces the level of DIAP1.lacZ 
expression. The dotted lines in C, D, G and H outline the posterior compartment marked by the 
expression of a UAS.GFP transgene (not shown). 
Chapter 4. Drosophila mask characterisation 
 83 
       
 
Figure 4.9: mask is required for Yki target gene expression (2) 
MARCM clones in the pouch of third instar wing imaginal discs (distal region). (A) A mask10.22 
homozygous mutant clone (GFP-positive) shows reduced expression of fj.lacZ detected by the β-
galactosidase antibody (red) compared to control neighbouring cells (A’). 
(B) A mask10.22 homozygous mutant clone (GFP-positive) shows reduced expression of ex.lacZ 
detected by the β-galactosidase antibody (red) compared to control neighbouring cells (B’). 
(C) A mask10.22 homozygous mutant clone (GFP-positive) shows reduced expression of 
DIAP1.lacZ detected by the β-galactosidase antibody (red) compared to control neighbouring 
cells (C’). 
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Figure 4.10: Mask binds to Yki 
 (A) Schematic diagram of the Mask protein domain structure and the cloned domains 
(B-D) Localisation of ANKRI-Flag (B), ANKRII-Flag (C) and ANKRII+KH-Flag (D) constructs upon 
expression in Drosophila S2R+ cells (anti-Flag immunostaining). 
(E) Co-immunoprecipitation of GFP-tagged Yki with Flag-tagged Mask ankyrin repeat domains 
(ANKRI, ANKRII, or ANKRII+KH). S2 cells were transfected with an EGFP-Yki plasmid and a FLAG 
vector either empty or containing Mask conserved domains ANKRI or ANKRII or ANKRII+KH. 
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To further investigate the relationship between Mask and Yki, we examined their 
subcellular localisation by immunostaining in Drosophila tissues and cultured cells (Fig 
4.11). Both proteins localised in a very similar pattern, predominantly cytoplasmic in 
the developing wing disc epithelium and more nuclear in cultured S2R+ cells, where the 
two proteins also localise in perinuclear dots (Fig 4.11 A-C).  In the Drosophila adult 
gut, Yki has been shown to be upregulated and to translocate into the nucleus upon 
stress – such as infection or activation of JNK signaling – to promote gut regeneration 
(Shaw et al., 2010) (Staley and Irvine, 2010). We examined Mask and Yki localisation in 
the gut and found that the 2 proteins also co-localise and appear to move together 
into the nucleus in some regions of the gut (Fig 4.11 D-E). The Drosophila adult gut 
epithelium is mostly composed of large enterocytes (ECs), which ensure the absorptive 
function of the intestine (Fig 4.12 A). The maintenance of the epithelium is ensured by 
small diploid intestinal stem cells (ISCs), which are localised basally in the epithelium. 
The ISC divides to produce an ISC and a progenitor cell, the enteroblast (EB), which 
then divides to produce ECs and occasionally small entero-endocrine cells (ee) (Fig 
4.12 B). In flies expressing a UAS.GFP construct under the control of the EC specific 
driver MyoIA.GAL4, we found that both Mask and Yki were upregulated together in 
some isolated ECs, and in small GFP negative cells (presumably ISCs and EBs, as Yki was 
shown to be upregulated in those cells upon stress) (Fig 4.12 C-F). Thus, Mask 
colocalises with Yki and may be subject to the same regulation in response to stress.  
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Figure 4.11: Mask colocalises with yki in Drosophila cells and tissues 
Immunostainings for Mask (in green) and Yki (in red), nuclei are stained with DAPI (blue) 
(A-B) Mask and Yki co-localise in both nucleus and cytoplasm of cultured S2R+ cells. (C) Mask 
and Yki co-localise in the cytoplasm of wing imaginal disc epithelial cells. (D) Mask and Yki co-
localise in the cytoplasm of resting adult midgut intestinal cells. (E) Mask and Yki co-localise in 
both nucleus and cytoplasm of regenerating adult midgut intestinal cells. 
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Figure 4.12: Mask is co-expressed with Yki in isolated enterocytes and progenitor 
cells in the adult midgut. 
(A) Schematics of the intestinal epithelium from (Shaw et al., 2010). EC: enterocyte. ISC: 
intestinal stem cell. ee: entero-endocrine cell. EB: enteroblast. The gut is covered by a muscle 
layer. (B) Diagram of an ISC progeny  
(C) Portion of an adult midgut with nuclei stained with DAPI (blue), ECs are marked by the 
expression of GFP (green) (D). Immunostaining for Mask (pink, E) and Yki (red, F) reveals that the 
two proteins are upregulated together in isolated enterocytes (asterisks) and progenitor cells 
(arrows).  
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4.2.3  Mask is required for Yki activity 
Taken together, our results strongly suggest that Mask acts at the level of Yki in the 
Hippo pathway. To analyse the role of Mask in Yki regulation, we performed a genetic 
epistasis experiment in the wing imaginal disc. The MARCM system was used to over-
express a V5-tagged Yki construct in clones of cells either control or mutant for mask. 
Over-expression of V5-tagged Yki in clones of cells is sufficient to cause a strong over-
proliferation phenotype compared to wild type clones (Fig 4.13 A,B).  In contrast, when 
V5-tagged Yki is over-expressed in mask10.22 mutant clones, it is no longer able to 
induce over-proliferation (Fig 4.13 C-E). Thus, mask is required for over-expressed Yki 
to drive cell proliferation. This effect could be indirect: mask may be essential for cell 
survival independently of Yki. However, considering the binding of Mask to Yki, their 
cytoplasmic/nuclear co-translocation, and mask specific effects on Yki target gene 
expression, mask10.22 effect on Yki-dependent cell over-proliferation is more likely to be 
specifically through Yki regulation.  
4.2.4  Mask affects the level of Yki phosphorylation  
A major regulator of Yki activity is the Warts kinase (Wts), which negatively regulates 
Yki by phosphorylating it on three conserved Serine residues (S111, S168, S250), one 
of which – S168 – is most crucial to regulate Yki activity (Oh et al., 2009). Activation 
of Wts in the eye by overexpression of its activating kinase Hpo is sufficient to induce 
a strong undergrowth phenotype, similar to that of mask mutant phenotype (Wu et al., 
2003). As Mask appears essential for Yki activity, it may be required to limit Yki 
phosphorylation by Wts. To test this hypothesis, we made use of an anti-phospho-
S168 Yki antibody (N. Tapon) to compare Yki levels of phosphorylation in control and 
mask mutant larvae. As mask10.22 homozygous mutant is embryonic lethal, we used a 
combination of two hypomorphic alleles, both homozygous lethal: mask6.3 and mask7.29 
(Smith et al., 2002). mask6.3/TM3SerGFP females were crossed to mask7.29/TM3SerGFP 
males and GFP expression in the progeny was used to identify the genotypes. GFP 
negative mask6.3/mask7.29 transheterozygous larvae are viable but grow much smaller 
than wild type and die before pupariation. 20 GFP positive larvae (mask6.3/ TM3SerGFP 
or mask6.3/ TM3SerGFP: control) and 20 GFP negative mask mutant larvae 
(mask6.3/mask7.29) of similar sizes were collected. Proteins from each sample were 
extracted and analysed by Western blot with the anti-phospho-S168 Yki antibody. We                     
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Figure 4.13: Overexpressed Yki requires Mask to drive cell proliferation  
Third instar wing imaginal discs. Nuclei are marked with DAPI (blue). Clones, marked by the 
expression of NLS-GFP (green), were generated using the MARCM system and induced by heat 
shocking larvae at 84 hr (± 12 hr) of development.  
(A) Control clones (GFP-positive)  
(B) Overexpression of Yki-V5 in clones drives overproliferation of cells, leading to enlarged clone 
sizes. 
(C) Mutation of mask inhibits cell proliferation, resulting in small clones. 
(D) Overexpression of Yki-V5 in mask mutant cells fails to drive overproliferation, resulting in 
small clones. 
(E) Quantification of clone sizes in (A-D). 
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found that phospho-Yki levels were elevated in mask mutant larvae compared to 
control larvae (Fig 4.14). This effect was repeated between different sets of 
experiments. However, its extent was variable and on average mild.  Thus, Mask has a 
mild negative effect on the ability of Wts to phosphorylate Yki. 
 
 
Figure 4.14: Mask affects Yki phosphorylation.  
Homozygous mask mutant larvae exhibit elevated levels of phosphorylated Yki, as detected by a 
western blot using an anti-phospho-Ser168-Yki antibody. 
 
4.3  Mask promotes Yki function in the nucleus 
4.3.1  Mask is essential for activated Yki function downstream of Warts 
If mask unique role was to antagonise Yki phosphorylation by Wts, then mutation of 
wts should fully rescue mask mutant. Mask and wts are both located on the right arm 
of chromosome 3, allowing the recombination of mask and wts alleles for epistasis 
experiments. mask10.22 allele was recombined with 2 different alleles of wts: wtsM541 
(hypomorph) and wtsX1 (null). We used the eyFlp FRT minute system to generate whole 
mutant and double mutant eyes for mask10.22 and wtsM541 alleles. wtsM541 mutant eyes 
were strongly overgrown, but wtsM541 mutation was not able to rescue the growth of 
mask10.22 wtsM541 double mutant eye (Fig 4.15 A-D). We also tested mask and wts 
epistasis in clones in the wing disc using wtsX1 null allele, which was pupal lethal with 
the eyFlp FRT M system. We find that, compared with wtsX1 mutant clones, which 
strongly overproliferate, mask10.22 wtsX1 double-mutant clones still show impaired 
proliferation (Fig 4.15 E-I).  Thus, Mask is required for active, non-phosphorylated Yki 
to drive overproliferation.   
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To confirm these results, we used the MARCM system to test the ability of 2 non-
phosphorylatable (activated) forms of Yki to rescue mask mutant phenotype compared 
to the wild-type Yki-V5 construct mentioned previously (paragraph 4.2.3). The 3 Yki-
V5 transgenes are all inserted in the same location in the genome and only differ in 
point mutations affecting Wts phosphorylation sites (Oh and Irvine, 2009). The 
strength of their phenotypes can thus be compared:  
‐ Yki-V5, V5 tagged wild-type Yki  ‐ Yki S168A -V5, V5 tagged mutant Yki that contains a substitution of Serine 168 
to Alanine ‐ Yki S111A-S168A-S250A -V5 (Yki3SA -V5), V5 tagged mutant Yki that contains 
substitutions of Serine111, Serine168 and Serine250 to Alanines.  
Clones expressing either of these constructs overproliferate compared to control wild 
type clones (Fig 4.16). As expected, expression of activated forms of Yki induce a 
stronger overgrowth than expression of the wild type Yki, the strongest phenotype 
being that of the triple mutant: overgrown clones of cells overexpressing Yki-V5S168A or 
Yki-V5S111A-S168A-S250A cause folds in the tissue and start extruding from the wing disc 
epithelium. Expression of these activated forms of Yki could partially rescue mask10.22 
mutant clones in the hinge region of the wing disc but the clones were still much 
smaller than control clones expressing activated Yki. Moreover, mutant clones in the 
centre of the pouch were not rescued. Thus, none of the constructs was able to fully 
rescue mask10.22 mutant: Mask is essential for activated Yki to drive cell proliferation. 
Taken together, these results show that Mask acts downstream or at the level of Wts 
and is essential for activated Yki function.  
Two hypotheses could explain Mask requirement for activated Yki function:  
1) Mask may be involved in Yki nuclear translocation 
2) Mask may be involved in transactivation of Yki target genes in the nucleus 
 
Chapter 4. Drosophila mask characterisation 
 92 
4.3.2  Mask does not regulate Yki nuclear localisation 
To determine if Mask was involved in Yki nuclear translocation, we examined Yki 
localisation in mask mutant clones in the wing disc using a Yki antibody (Yki69, N. 
Tapon). No change in Yki localisation was detectable in those clones (Fig 4.17 A-D). 
However, detection of endogenous Yki in the nucleus is difficult with current available 
antibodies.  In order to confirm this result, we examined the localisation of Yki-V5 in 
mask mutant clones compared to control clones (Fig 4.17 E-F’).  In control cells, Yki-V5 
localises mostly in the cytoplasm but is also detectable in the nucleus. Despite the 
strong undergrowth of mask mutant cells overexpressing Yki-V5, no detectable 
difference in Yki-V5 localisation was observed in those mutant cells compared to 
controls. Similar results were obtained when looking at the localisation of Yki S168A -V5 
and Yki S111A-S168A-S250A-V5 (Appendix, Fig A.2). Thus, the undergrowth phenotype of 
mask mutant clones expressing Yki-V5 is not due to a defect in Yki-V5 translocation 
into the nucleus. These results show that Mask does not regulate Yki nuclear 
localisation.  
 
 
Chapter 4. Drosophila mask characterisation 
 93 
 
Figure 4.15: Mask acts downstream or at the same level as Wts 
(A-D) Scanning electron Micrographs of Drosophila heads processed by CRUK Electronic 
Microscopy Unit. (A) Control Drosophila head, top view. (B) mask10.22 mutation in the eye results 
in abnormally small eyes. (C) wtsM541 hypomorphic mutation in the eye results in an abnormally 
large eye. (D) wtsM541mutation in the eye cannot rescue the undergrowth phenotype of mask10.22 
mutation. (E-H) Third instar wing imaginal discs. Nuclei are marked with DAPI (blue). Clones, 
marked by the expression of NLS-GFP (green), were generated using the MARCM system and 
induced by heat shocking larvae at 84 hr (± 12 hr) of development. (E) Control clones (GFP-
positive) in a third instar wing imaginal disc. (F) mask10.22 mutant clones proliferate slowly, 
leading to small clone sizes. (G) wtsX1 mutant clones overproliferate, leading to enlarged clone 
sizes. (H) mask10.22 wtsX1 double mutants grow to larger sizes than mask10.22 mutants, but are 
still much smaller than wtsX1 mutants, indicating that even fully activated Yki requires Mask to 
drive cell proliferation.(I) Quantification of clone sizes in (E-H). 
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Figure 4.16: Activated Yki expression does not fully rescue the growth of mask 
mutant clones 
Third instar wing imaginal discs. Nuclei are marked with DAPI (blue). Clones, marked by the 
expression of NLS-GFP (green), were generated using the MARCM system and induced by heat 
shocking larvae at 84 hr (± 12 hr) of development. (A) Control clones (GFP-positive).  
Clones overexpressing Yki-V5 (B), YkiS168A-V5 (C) and Yki3SA-V5 (D) overproliferate, leading to 
enlarged clone sizes. Activated forms of Yki present stronger phenotypes. (E) mask10.22 mutant 
clones proliferate slowly, leading to small clone sizes. (F-H) mask10.22 mutant clones are not 
recued by Yki-V5 overexpression (F) and are only partially rescued by YkiS168A-V5 (G) and Yki3SA-
V5 (H) overexpression. 
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Figure 4.17: mask mutant does not affect Yki nuclear localisation 
(A-D) Clones mutant for mask10.22 induced with the MARCM system (A, green) do not alter the 
subcellular localisation of Yki (B, red) in the wing imaginal disc. (C) DAPI (blue) marks nuclei.  
(E) Yki-V5 expressed in a clone with the MARCM system localises in the cytoplasm and the 
nucleus (anti-V5, red). Nuclei are marked by DAPI (blue) and a dotted line outlines the clone (E’).  
(F) Yki-V5 expressed in a mask10.22 mutant clone with the MARCM system is still able to localise in 
the nucleus (anti-V5, red). Nuclei are marked by DAPI (blue), and a dotted line outlines the clone 
(F’).  
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4.3.3  Mask acts with Yki in the nucleus to activate its target genes 
As Mask is essential for Yki function but mask mutant does not affect Yki nuclear 
translocation, Mask may be involved in regulating Yki transactivation in the nucleus. To 
test this hypothesis, we examined activated Yki capacity to activate its target genes in 
the absence of Mask. We generated single and double mutant clones for mask and wts 
in wing discs carrying the ex.lacZ or fj.lacZ reporters. In wtsX1 mutant clones, Yki is 
more active and this can be measured by an increase in ex.lacZ expression (Fig 4.18 A). 
By contrast, induction of ex.lacZ is impaired in wtsX1 mask10.22 double-mutant clones in 
the wing pouch (Fig 4.18 B). Similarly, fj.lacZ expression remains low in wtsX1 mask10.22 
double-mutant clones in the wing pouch (Fig 4.18 C).  Induction of fj.lacZ was not 
detectable in wtsX1 mutant clones in the wing pouch, but it could be detected in some 
clones in the hinge region. This may be due to the fact that in the distal region of the 
wing disc, fj expression is already very strong. In addition, it is controlled by other 
unknown signals. Thus, Mask is required for Yki target gene up-regulation in wts mutant 
clones, supporting the hypothesis that Mask acts by promoting transactivation of Yki 
target genes in the nucleus. 
A more detailed examination of mask wts double mutant clones revealed a difference in 
the requirement for Mask in Yki reporter gene expression. While double mutant clones 
in the inner (distal) region of the wing disc present no change in target gene expression 
or sometimes a downregulation, some clones in the outer region present a mild 
upregulation of these reporter genes (Fig 4.19). Yki target gene upregulation 
correlates with a partial rescue of cell proliferation. Thus, Mask is less required for Yki 
activity in the hinge region of the wing disc, indicating that Yki may be more active in 
this region. This may explain why mask mutant clones are also partially rescued by 
activated forms of Yki specifically in the proximal region of the wing disc (Fig 4.16 
G,H).  
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Figure 4.18: Mask regulates Yki target gene activation 
MARCM clones marked by the expression of NLS-GFP (green) in third instar imaginal discs 
immunostained for β-galactosidase (red). DAPI marks nuclei (blue)  
(A-A’) ex.lacZ is up-regulated in wtsX1 mutant clones (wing pouch) 
(B-B’) mask10.22 wtsX1 double mutant clones fail to upregulate ex.lacZ expression (wing pouch, 
proximal edge) 
(C-C’) mask10.22 wtsX1 double mutant clones fail to maintain fj.lacZ expression (wing pouch) 
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Figure 4.19: Different requirement for Mask in distal region versus hinge region in 
the wing imaginal disc 
MARCM clones marked by the expression of NLS-GFP (green) in third instar imaginal discs 
immunostained for β-galactosidase (red). DAPI marks nuclei (blue)  
(A-A’) wtsX1 mutant clones show mild upregulation of fj.lacZ expression in the hinge region 
(arrows) (B-B’) fj.lacZ expression is down-regulated in mask10.22 wtsX1 double mutant clones in 
the wing pouch (arrow head) but is slightly upregulated in clones in the hinge region (arrow).  
(C) wtsX1 mutant clones show upregulation of ex.lacZ expression (D) mask10.22 wtsX1 double 
mutants fail to maintain ex.lacZ expression in the wing pouch but ex.lacZ is slightly upregulated in 
clones in the hinge region (arrows). 
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4.3.4  Wts does not regulate Mask 
Altogether, these data strongly suggest that Mask is an essential co-activator of Yki in 
the nucleus. As Mask localises in a similar pattern to Yki and translocates with Yki in the 
nucleus, it may be regulated by Wts in the same way as Yki is. In order to test this 
hypothesis, we examined Mask localisation in wtsX1 mutant clones using Mask antibody 
(Fig 4.20). Mask protein levels and localisation were not affected. Thus, Wts does not 
regulate Mask nuclear translocation or Mask stability. In addition, this result shows that 
mask is not a target gene of the Hippo signaling pathway.   
 
Figure 4.20: Wts does not regulate Mask localisation and level of expression 
wtsX1 FLP/FRT mutant clones (dotted line) in a third instar larva wing imaginal disc. The mutant 
clones are marked by the absence of GFP (A), and have no effect on Mask protein levels or 
localisation detected by immunostaining (B) 
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Chapter 5.   Mask function in Yki/YAP regulation is 
conserved in humans 
5.1 Mask proteins 
Drosophila Mask is well conserved across metazoans and has two homologues in 
human: ANKHD1 or Mask1, and ANKRD17 or Mask2. The two human proteins are 
smaller than Drosophila Mask but both contain the 2 blocks of ankyrin repeats, the KH 
domain, and the putative NES and NLS, which are all highly conserved (Fig 5.1).  
5.1.1  hMask1  
Human Mask1 is a ubiquitously expressed protein of 2542 amino acids. One isoform of 
Mask1 (VBARP) has been shown to be important for cell survival and to prevent 
apoptosis (Miles et al., 2005). Other isoforms of Mask1 were found strongly 
upregulated during haematopoietic cell differentiation (Santos Duarte et al., 2005). A 
functional study of Mask1 was done following the track of Drosophila Mask genetic 
interaction with Corkscrew (Smith et al., 2002). Corkscrew homologue in human is the 
protein-tyrosine phosphatase SHP2 (Freeman et al., 1992). Like Csw, SHP2 promotes 
Ras/MAPK signaling. It regulates numerous processes like cell growth, differentiation, 
migration and death, and does not solely act through Ras/MAPK signaling (Feng, 
1999).  SHP2 has been implicated in human diseases, including 3 different types of 
leukemias and found overexpressed in leukemia cell lines (Grossmann et al., 2010; Neel 
et al., 2003). Traina et al investigated the potential link between Mask1 and SHP2 
(Traina et al., 2006). They found that Mask1 was overexpressed in leukemia cell lines 
and samples from leukemia patients. Besides this, Mask1 co-immunoprecipitates with 
SHP2 in 2 different cell lines. However, this association was not found in 4 other 
leukemia cell lines with high levels of both proteins. Thus, there may be a link between 
Mask1 and SHP2 but it is not a clear one.  
5.1.2  hMask2  
Human Mask2, a protein of 2603 amino acids, was originally identified in a screen for 
genes that respond to retinoic acid (Forrester et al., 1996). It has two alternative 
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promoters, one of which is activated in the liver lineage, and one that drives Mask2 
expression ubiquitously (Watt et al., 2001).  
Mask2 was recently identified as a substrate of cyclinE/Cdk2, the cyclin/Cdk complex 
that promotes G1/S transition during the cell cycle (Deng et al., 2009). Deng et al 
show that Mask2 is essential to promote cell proliferation in cultured cells. 
Furthermore, Mask2 is found in the cytoplasm and associated with chromatin during all 
phases of the cell cycle except in mitosis, where it is still present but not chromatin 
associated. Deng et al find that Mask2 co-immunoprecipitates with DNA replication 
factors and conclude that Mask2 is a general cell cycle regulator of G1/S transition that 
may be directly involved in DNA replication. Another study published the same year 
describes Mask2 as an essential regulator of vascular development (Hou et al., 2009). 
Hou et al generated Mask2 deficient mice and found that homozygous mutant embryos 
die between embryonic day (E) 10.5 and E11.5. These Mask2 mutant embryos present 
growth retardation and defects in vasculogenesis, with a pale yolk sac due to poor 
blood circulation. Interestingly, this phenotype is similar, although less severe,  to that 
of YAP, the human homologue of Yki: embryos mutant for YAP present severe defects 
in growth and yolk sac vasculogenesis (Morin-Kensicki et al., 2006). The fact that cells 
in Mask2 mutant embryos can proliferate until E11.5 is not consistent with a role of 
Mask2 as a general cell cycle regulator as proposed by Deng et al. However, the growth 
retardation phenotype is consistent with a role of Mask2 in controlling cell proliferation.  
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Figure 5.1: Mask protein is conserved in human  
Sequence alignment of Drosophila Mask, human Mask1 and human Mask2 proteins, ClustalW2 
program (Larkin et al., 2007). (A) Alignment of the first conserved block of ankyrin repeats (B) 
Alignment of the second conserved block of ankyrin repeats (C) Alignment of the KH domain 
region. 
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5.2 hMask proteins colocalise with YAP in human cells 
In Drosophila, Mask colocalises and translocates with Yki into the nucleus. We examined 
Mask1 and Mask2 localisation in human cell cultures to determine if they behave the 
same as Drosophila Mask. YAP is known to become cytoplasmic upon cell-contact 
inhibition in certain human cancer cell lines, such as MCF10a cells (Zhao et al., 2007).  
We find that Mask1 and Mask2 co-localise with YAP in the cytoplasm of confluent 
MCF10a cells (Fig 5.2 A,B).  By contrast, in malignant HEK293 cancer cells, which are 
resistant to contact inhibition, YAP is predominantly nuclear. In those cells, both Mask1 
and Mask2 follow YAP pattern and localise in the nucleus (Fig 5.2 C,D). Note that 
Mask2 is more nuclear than Mask1. Translocation of Mask1, Mask2 and YAP from 
cytoplasm to nucleus is best observed in Caco2 cells, where the three proteins are 
cytoplasmic in confluent cells but strongly nuclear in less densely packed cells (Fig 5.2 
E,E’,E’’).  These results show that human Mask proteins, like their Drosophila 
counterpart, translocate with Yki/YAP between the cytoplasm and the nucleus in 
response to a stimulus, in this case cell-contact inhibition. Interestingly, hMask1 and 
hMask2 were sometimes observed with YAP at cell junctions (Fig 5.3) 
Recent publications have shown that YAP is expressed in epithelial progenitor cells, 
where it is required and promotes cell proliferation (Camargo et al., 2007; 
Schlegelmilch et al., 2011; Zhang et al., 2011a). Epithelial tissue sections from human 
oesophagus were stained for Mask1, Mask2 and YAP by the Cancer Research UK 
Experimental HistoPathology laboratory. We find that the three proteins are strongly 
expressed in the basal cell layer of epithelial tissues – the zone of stem/progenitor cells 
(Fig 5.4).  Note that in these tissue sections Mask2 appears more nuclear while Mask1 
appears more cytoplasmic.   
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Figure 5.2: Human Mask proteins colocalise with YAP 
Human cells immunostained for YAP, Mask1 and Mask2. Nuclei are stained with DAPI. 
(A) Human Mask1 and YAP co-localise in the cytoplasm of MCF10A cells. (B) Human Mask2 and 
YAP co-localise in the cytoplasm of MCF10A cells. (C) Human Mask1 and YAP co-localise in the 
cytoplasm and nucleus of HEK293 cells. (D) Human Mask2 and YAP co-localise in the cytoplasm 
and nucleus of HEK293 cells, nuclei are stained with DAPI. (E) Human Mask1, Mask2 and YAP 
show similar redistribution from the nucleus to the cytoplasm upon contact inhibition in CACO2 
cells (low magnification view). (E’) Human Mask1, Mask2 and YAP co-localise in the nucleus in 
low-density Caco2 cells (high magnification view). (E’’) Human Mask1, Mask2 and YAP co-localise 
in the cytoplasm in high-density Caco2 cells (high magnification view). Immunostainings in 
HEK293 and MCF10A cells were done in collaboration with Ruth Brain in the laboratory.  
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Figure 5.3: Mask protein are sometimes found with YAP at cell junctions 
Caco2 cells immunostained for YAP (A), hMask1 (B), and hMask2 (C). Localisation of YAP and 
hMask proteins at cell junctions is indicated by arrows. 
 
 
Figure 5.4: Human Mask proteins are coexpressed with YAP in epithelial stem cells 
(A) YAP is mainly nuclear in the basal stem cell layer of human oesophageal epithelia. 
(B) Mask1 is mainly cytoplasmic in the basal stem cell layer of human oesophageal epithelia. 
(C) Mask2 is mainly nuclear in the basal stem cell layer of human oesophageal epithelia. 
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5.3  Mask 2 is essential for YAP transactivation activity 
In order to test if human Mask proteins have a role in regulating Yki/YAP activity like 
their Drosophila homologue, we made use of a YAP-dependent transcription reporter 
assay (Zhao et al., 2008). HEK293T cells were transfected with a plasmid containing a 
UAS.luciferase reporter construct and a plasmid containing TEAD4 (Scalloped 
homologue) fused to the GAL4 DNA binding domain (G4-TEAD4). Transfection of G4-
TEAD4 on its own was not able to drive significant expression of the UAS.luciferase 
reporter, but transfection of non-phosphorylatable Flag-tagged YAP5SA together with 
G4-TEAD4 strongly induced expression of the reporter (Fig 5.5 A,B). We made use of 
siRNA pools targeting Mask1 and Mask2 to efficiently knock-down the two proteins (Fig 
5.5 C) and found that knock-down of Mask1 had no effect on YAP-dependent 
transcription, but knockdown of Mask2 caused a significant decrease in reporter gene 
activity (Fig 5.5 B). This decrease is not due to an effect on YAP phosphorylation, as 
we used a non-phosphorylatable form of YAP. Hence, this result strongly suggests that 
hMask2 is required to promote YAP activity in the nucleus. Thus, Drosophila Mask 
function in controlling Yki/YAP activity is conserved in human and is ensured by Mask2.  
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Figure 5.5: hMask2 regulates YAP transactivation activity 
(A) Schematics of the TEAD/Luciferase reporter system: co-expression of YAP5SA with G4-TEAD4 
activates the transcription of the UAS.Luciferase reporter. (B) TEAD/Luciferase reporter assay 
results graph. Expression of YAP5SA with the TEAD/Luciferase reporter produces a strong 
increase in Luciferase expression compared to G4-TEAD4 alone. siRNA mediated RNAi knock-
down of hMask2, but not hMask1, significantly reduces YAP5SA activity. (C) Control Western blot 
[from Ruth Brain] showing Mask1, Mask2 and YAP5SA levels upon siRNA knock down of Mask1 or 
Mask2. Mask1 and 2 knock-down is efficient and it does not affect YAP5SA stability.  
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Chapter 6.  Discussion  
 
Lessons from the screen 
Our laboratory has carried out the first in vivo RNAi screen for novel regulators of 
tissue growth in Drosophila, making use of the newly developed VDRC transgenic RNAi 
library. This screen has successfully led to the discovery of conserved growth 
regulators including Mask and Kibra (Sidor et al, in preparation)(Genevet et al., 2010). 
The use of the wing, which is precisely patterned by several conserved signaling 
pathways, has allowed precise classification of candidate genes according to their 
growth phenotypes and other morphological defects. This classification has enabled us 
to link mask and kibra to the Hippo signaling pathway, as both genes presented cell 
proliferation phenotypes without patterning defects, like known genes from this 
pathway. Other candidate genes, some of which are being investigated in the 
laboratory, have been linked to all classes of phenotypes and may therefore lead to the 
identification of several new members of known signaling pathways.  
 
We have estimated the efficiency of the RNAi screen at about 50%, meaning that 50% 
of the RNAi transgenic lines produce a knock-down sufficient to trigger a phenotype. In 
addition, our attempt to validate candidate genes by second RNAi transgenic lines has 
brought to light the importance of such confirmation to eliminate off-target and mis-
expression artefacts. This validation process has not been done systematically by other 
laboratories who have carried out genome-wide RNAi screens using the VDRC library, 
and a significant proportion of their candidate genes may be false-positives (Mummery-
Widmer et al., 2009; Neely et al., 2010a; Neely et al., 2010b; Schnorrer et al., 2010). 
Candidate gene validation will be made easier by the development of new libraries, such 
as the VDRC KK library, the NIG-fly library and the TRIP library (http://www.flyrnai.org). 
Thus, future in vivo RNAi screens should be carried out using multiple RNAi libraries in 
order to produce highly reliable lists of candidate genes free from false positives, and 
to reduce the number of false negatives by increasing the number of RNAi lines tested 
for each gene.  
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The mask gene acts in the Hippo signaling pathway 
My results identify the mask gene as a novel component of the Hippo signaling 
pathway. Mask regulates Hippo pathway target gene expression and is required for Yki 
activity. It colocalises with Yki in both the cytoplasm and the nucleus and it binds to Yki 
through its conserved ankyrin repeats. In addition, Mask translocates simultaneously 
with Yki/YAP into the nucleus in Drosophila adult gut cells and upon cell contact 
inhibition in human cultured cells. Although Yki phosphorylation levels slightly increase 
in the absence of mask, suggesting a role for Mask in reducing Yki phosphorylation, the 
growth defects of mask mutant clones cannot be rescued either in mask wts double 
mutant clones, in which Yki is not phosphorylated by Wts, or by expression of non-
phosphorylatable forms of Yki.  Thus, mask function is required for non-phosphorylated 
Yki activity. Moreover, Mask is not required for Yki nuclear translocation as Yki is able to 
localise in the nucleus of mask mutant cells. Taken together, these data indicate that 
mask is required for Yki activity in the nucleus.  
In support of this idea, we find that mask is required for activated Yki target gene 
upregulation in wts mutant clones. Furthermore, in human cells, RNAi knock-down of 
hMask2 reduces the activity of YAP in a transcriptional reporter assay, suggesting a 
conserved role for Mask proteins in the regulation of Yki/YAP transactivation activity. 
We have not yet detected any redundancy between hMask1 and hMask2 in the control 
of YAP dependent transcription activation, and we have not yet been able to 
demonstrate any role for hMask1 in YAP regulation.  Nevertheless, both hMask1 and 
hMask2 are able to bind YAP in co-immunoprecipitation experiments (recent data from 
Ruth Brain), indicating that hMask1 is likely to regulate YAP. Moreover, both hMask1 
and hMask2 are co-expressed with YAP in human epithelial progenitor cells. The Mask2 
KO mouse phenotype resembles that of YAP KO but is less severe. It would be 
interesting to investigate the phenotype of Mask1/Mask2 double KO to see if it 
resembles more YAP phenotype.  
Mask and RTK signaling 
Mask was previously identified in a modifier screen for regulators of Receptor Tyrosine 
Kinase signaling but does not affect the activation of MAPK, suggesting a role in 
parallel or downstream of MAPK (Smith et al., 2002). Although our data show that 
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Mask acts in the Hippo signaling pathway, and although mask mutant phenotypes look 
distinctly different from Ras signaling mutant phenotypes, we cannot rule out some 
role for mask with the Ras signaling pathway, since mask does interact genetically with 
Ras signalling components in the fly eye. However, these results must be interpreted 
carefully as both Ras signaling and Hippo signaling are known to affect cell survival 
independently of each other. Indeed, genetic interactions between functionally 
unrelated genes affecting the same cellular processes are a known source of false 
positive artefacts in modifier screens (St Johnston, 2002).  
Some ‘crosstalk’ between Hippo signaling and Ras signalling has been suggested from a 
study in human cultured cells, where YAP was found to induce the expression of the 
EGFR ligand amphiregulin (AREG) which mediates cell proliferation in a non-autonomous 
manner (Zhang et al., 2009b). In addition, Zhang et al show a genetic interaction 
between EGFR signaling and Hippo signaling in the Drosophila eye, where mutants of 
EGFR signaling components slightly enhance the undergrowth phenotype of Wts or Hpo 
overexpression. In the Drosophila midgut, loss of Hippo signaling in ECs leads to the 
production of EGFR ligands that activate EGFR signaling in neighbouring ISCs, shown by 
an increase in the levels of phosphorylation of the MAPK ERK (Ren et al., 2010). 
However, these non-autonomous effects of Hippo signaling on RTK signaling do not 
explain why Mask would affect RTK signaling without affecting MAPK activation.  
Upstream regulation of Mask 
Several lines of evidence suggest that Mask’s subcellular localisation is regulated. The 
localisation of Drosophila Mask correlates with that of Yki, being more cytoplasmic in 
the wing disc, and more nuclear in S2R+ cells. In the Drosophila adult gut, Mask 
translocates with Yki to the nucleus in stressed guts and both proteins are upregulated 
in isolated enterocytes and progenitor cells in normal guts. As Mask seems to be co-
regulated with Yki, we tested in the wing disc if Wts could regulate Mask. However, we 
found that Mask localisation was not affected in wts mutant clones, indicating that 
Mask is regulated in a Wts-independent manner.  Nevertheless, Mask proteins relocalise 
in response to stress in Drosophila and in response to cell contact inhibition in human 
cells, indicating that they may be regulated by the same stimuli as Yki/YAP/TAZ.  
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In the Drosophila adult gut, increases in Yki levels and nuclear localisation are triggered 
by stress such as bacterial infection or toxic chemicals, to promote tissue regeneration. 
This response to stress involves the JNK signaling pathway, which was shown to 
promote Yki nuclear localisation in the adult gut but also in the larval wing disc, where 
Yki is also involved in regeneration upon tissue damage (Grusche et al., 2011; Shaw et 
al., 2010; Staley and Irvine, 2010). Indeed, damaging the wing disc by localised 
expression of pro-apoptotic genes such as reaper induces nuclear accumulation of Yki 
in cells neighbouring the wound. It will be interesting to examine Mask localisation in 
that context. Specifically, in order to test whether Mask can be regulated by JNK 
signaling, it will be interesting to investigate Mask localisation in clones of cells 
overexpressing an activated form of the JNK kinase Hemipterous (Hep) in the adult gut 
or in the larval wing disc where it has been shown to promote Yki nuclear translocation 
(Staley and Irvine, 2010; Sun and Irvine, 2011).  
In human cultured cells, we have found that Mask proteins translocate like YAP and TAZ 
from the nucleus to the cytoplasm in response to cell contact inhibition. YAP/TAZ were 
shown to be sequestered in the cytoplasm upon cell contact inhibition via a Hippo 
signaling dependent mechanism, but also independently via binding to tight junction 
Angiomotin family proteins and to α-catenin (Schlegelmilch et al., 2011; Silvis et al., 
2011; Zhao et al., 2011). It will be very interesting to investigate how Mask localisation 
is regulated upon cell contact inhibition, if it requires Hippo signaling, or if Mask 
proteins are regulated independently, maybe through interactions with adhesion or 
junction proteins such as E-Cadherin, catenins, or proteins from the Crumbs complex 
including Angiomotin. Indeed, hMask proteins were sometimes observed localised with 
YAP at cell junctions. 
Mask is a novel transcriptional co-activator 
Our data indicate that Mask is a transcriptional co-activator required for Yki/YAP to 
activate its target genes in the nucleus. These results are also supported by the fact 
that Mask proteins contain conserved NLS and NES sequences, and localise in the 
nucleus. Moreover, hMask2 was shown to associate with chromatin during all phases of 
the cell cycle except mitosis (Deng et al., 2009), which is consistent with a role for 
hMask2 in transcription regulation, as most transcription is stopped during mitosis and 
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transcription factors dissociate from chromatin during that phase (Gottesfeld and 
Forbes, 1997).  
The presence of ankyrin repeats in Mask sequence does not suggest a specific 
function, as these protein-protein interaction domains are found in a wide variety of 
proteins of diverse localisations and functions (Michaely and Bennett, 1992). 
Interestingly however, ankyrin repeats can be found in nuclear proteins such as the 
yeast transcription factors SWI4 and SWI6 (Breeden and Nasmyth, 1987), and the 
mammalian GABPβ transcriptional co-activator (Batchelor et al., 1998).  
More importantly, Mask contains a highly conserved KH domain. The KH domain is 
known to bind single-stranded RNA or DNA, and was first identified in the human 
heterogenous ribonucleoprotein K (hnRNP K) (Valverde et al., 2008). hnRNP K was 
initially described as an RNA/RNP associated protein, but was later shown to be a 
transcriptional activator able to bind single-stranded DNA (ssDNA) secondary 
structures in the c-myc and VEGF promoters via its KH domains (Michelotti et al., 
1996; Takimoto et al., 1993; Tomonaga and Levens, 1996; Uribe et al., 2011). hnRNP 
K was also found to be activated upon DNA damage and required for p53 target gene 
expression, binding with p53 to target gene promoters in an interdependent manner 
(Moumen et al., 2005). Another example of transcriptional regulation involving a KH 
domain containing protein is the Ribosomal Protein S3 (RPS3), which is required for full 
activation of target genes by the NFκB transcription factor (Wan et al., 2007). RPS3 
translocates into the nucleus upon stimuli known to activate NFκB signaling, and 
strongly stabilises NFκB binding to DNA. A parallel can be established between hnRNP 
K/p53, RPS3/ NFκB, and Mask/Yki pairs of proteins. In all three cases, a KH domain 
containing protein translocates into the nucleus upon the same stimuli as its 
transcription activation partner and is required for target gene expression. Wan et al 
propose the very attractive idea that the KH domain binds to certain actively 
transcribed genes, which have open ssDNA due to the action of RNA polymerase, and 
then help transcription factors to bind to ssDNA sequences. This is very speculative in 
the case of Mask and Yki/YAP, and more experiments should be carried out to 
understand the exact mechanism of Yki/YAP target gene activation by Mask proteins.  
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It will be interesting to test if Drosophila Mask associates in a complex with any of the 
known partners of Yki such as Sd, Hth and Wbp2. As Mask ankyrin-repeat-domain 
binding to Yki is weak, it may be difficult to detect interaction between Mask and other 
Yki partners if the interaction is not direct. Co-immunoprecipitation experiments could 
be carried out using a cross-linking technique to ensure that the whole complex is 
pulled down.  
One key result that would confirm our hypothesis that Mask acts at the transcriptional 
level to activate Yki target genes would be to show the binding of Mask to a Yki/YAP 
target gene promoter. Thus, chromatin immunoprecipitation experiments should be 
carried out to test Mask binding to Yki/YAP target gene promoters both in Drosophila 
and human. For instance, it would be interesting to determine if Drosophila Mask binds 
the Hippo Responsive Element in DIAP1 promoter. In human cells, microarray and Q-PCR 
analysis of gene expression upon YAP or hMask knock-down will shed more light on the 
regulation of gene expression by these proteins. Furthermore, chromatin 
immunoprecipitaion experiments in cells treated with Mask RNAi could also help 
determine if Yki/YAP binding to its target genes is dependent on Mask proteins or if 
Mask proteins have a different role in gene activation.  
A new branch in Yki regulation? 
The Hippo signaling pathway was initially thought of as a linear pathway, with upstream 
components regulation converging on Hpo, and a linear cascade of regulatory 
phosphorylations leading to Yki cytoplasmic retention. However, this view was 
progressively challenged with the discovery of new entry points in Yki regulation. The 
upstream component Ex was found to regulate Yki cytoplasmic retention downstream 
of Wts through direct binding, the proteins Dachs, Zyxin and Ajuba modulate Hippo 
signaling by regulating Wts stability and activity downstream of Hpo, and the protein 
Myopic represses Yki activity downstream of Wts. Mask also acts downstream of Wts 
and is regulated by different signals, independently from the Hippo signaling cascade. 
Thus, Mask could be another entry point in the regulation of Yki, on which would 
converge other signals (Fig 6.1). Considering the increasing evidence for roles of 
mammalian Hippo signaling in tissue growth control during embryonic development, but 
also tissue regeneration, control of stem-cell proliferation, and cancer development, 
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and considering that Mask proteins seem critical for Yki/YAP/TAZ function, Mask 
proteins may also be crucial in those processes, and understanding how Mask is 
regulated will give new insight into how Yki/YAP/TAZ activity is controlled.  
 
 
Figure 6.1: Model of Mask function in Yki regulation 
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Table 2: List of candidates from the screen re-tested with NIG-FLY 2nd hairpin l ines 
Validated hits in yellow, lethal phenotypes in grey 
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Figure A.1: Mask conserved domains do not bind Sd 
Co-immunoprecipitation (Co-IP) of HA-tagged Sd or HA-tagged Yki with Flag-tagged Mask ankyrin 
repeat domains (ANKRI, ANKRII, or ANKRII+KH). Yki-HA but not Sd-HA binds to Mask ankyrin 
repeats.  
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Figure A.2: Wild-type and mutant forms of Yki can sti l l localise in the nucleus in 
the absence of Mask 
MARCM clones expressing different V5-tagged forms of Yki in third instar larvae wing discs 
immunostained for V5.  
(A) Yki-V5 localises in the cytoplasm and the nucleus  
(B) YkiS168A-V5 localises more strongly in the nucleus than Yki-V5 
(C) Yki3SA-V5 localises more strongly in the nucleus than Yki-V5 and YkiS168A-V5 
(D-F) In the absence of mask, the 3 forms of Yki are still able to localise in the nucleus 
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